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Solar ultraviolet radiation (UVR), especially UVA (320-400nm), is a potent inducer of 
oxidative DNA damage in human skin cells. Such damage has mutagenic and 
carcinogenic potential. It is therefore important to understand the mechanisms that 
control its extent, and develop means of protecting against such damage. The main 
purpose of this work was to develop reliable quantitative methods to measure UVR-
induced oxidative stress, assess its biological consequences and its inhibition, in human 
skin cells in vitro. Most of this work studied the effects of UVA radiation, as this is the 
major (>95%) component of solar UVR and readily generates reactive oxygen species 
(ROS). Particular focuses of this work were the measurement of UVA-induced ROS, as 
well as the formation of two of the most intensively studied DNA photolesions, the 
guanine-derived lesion 8-oxo-7,8-dihydroguanine (8-oxoGua), and the cyclobutane 
pyrimidine dimer (CPD). These were assessed by an enzyme specific comet assay. 
Vitamin E was used as a model antioxidant and treatment of HaCaT keratinocytes pre- 
but also post-irradiation was found to reduce ROS levels, as well as UVA-induced 8-
oxoGua and CPD formation. The post-UVR protection offered by vitamin E eliminated 
any possible sunscreen effects. Real-time PCR data of UVA-induced genes showed that 
vitamin E inhibited expression of heme oxygenase 1 (HO1) but not matrix 
metalloproteinase 12 (MMP12). Of three other antioxidants tested, only one (lanosterol) 
had an inhibitory effect on ROS and 8-oxoGua, but not on CPD formation. Studies with 
agents that modified ROS levels showed a clear link between ROS and 8-oxoGua but 
not CPD. Overall, the data showed that antioxidants have the potential to protect against 
potentially mutagenic epidermal DNA photodamage, an endpoint which, along with 
gene expression, can be readily applied to the in vivo human situation.  
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1.1 Solar radiation 
 
 
1.1.1 Historical perspective 
 
 
Human fascination with the sun and sunlight began from the dawn of mankind. The 
human race recognized its importance for vision, warmth and, eventually, agriculture 
and health. The sun has been an important aspect of all major civilizations, including the 
Egyptians, who worshipped the god Ammon Ra that presumably gave the naming of the 
word “radiation” (Bovie, 1918b), Assyrians, Babylonians and Greeks (god Helios).  The 
life-sustaining powers of the sun have been prominently displayed in ancient mythology 
and traditional culture. 
 
Around 450 BC, the Greek philosopher Anaxagoras faced trial and was imprisoned for 
claiming that the sun was not a god, but a big fiery rock and its light was reflected by 
the moon. A little later, close to 400 BC, the Athenian physician Hippocrates understood 
the sun’s healing powers and prescribed heliotherapy (sunbathing) for the treatment 
psychological and medical disorders.  
 
During the following century, Greek scholars studied optics, creating theories that 
attempted to explain vision, colour, light, and astronomical phenomena. Despite the fact 
that most of those theories were proven wrong, they initiated a gradual understanding of 
the relationship between the sun and living organisms (Hockberger, 2002). 
 
During the second century BC, Ptolemy, a Greek astronomer based in Alexandria 
(Egypt), wrote several books about optics, but only one of these survived to the modern 
world. His work was mostly dedicated to the study of reflection and refraction, using 
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mirrors of different shapes (Smith, 1996). Coming to the early modern period, during 
the 17th century, Sir Isaac Newton made some important observations; when a narrow 
beam of sunlight hit a glass prism at an angle, some was reflected, while some passed 
through the glass, coming out as different coloured bands (“colour rainbow”). He 
hypothesised that light consists of particles of various colours, moving at different 
speeds. Furthermore, Newton was the first to use the term “spectrum” (Latin for 
“appearance”) explaining his research in optics. Continuing to the 19th century, 
physicists accomplished a number of important theoretical and practical contributions 
that assisted in clarifying light’s properties. Specifically, in 1842, Becquerel managed 
to photograph the solar spectrum, using a slit to diffract sunlight, and a lens to focus the 
image onto a glass plate. He demonstrated that the emitted light was of longer 
wavelength than the incident light (fluorescence); this was the first indication of the 
spectrum of ultraviolet radiation (UVR) (Valeur and Brochon, 2001). Later on, more 
breakthroughs in the emerging science of photobiology followed. In the early 1860s, 
while he was a Professor of Natural Philosophy at King's College London, James Clerk 
Maxwell was the first to hypothesise that light was an electromagnetic wave. Hertz later 
confirmed this theory by showing that light travels in waves at discrete wavelengths. In 
the beginning of the 20th century, discoveries in photophysics from Planck, Einstein and 
Bohr and other major scientists led to today’s knowledge that radiation is comprised of 
photons that are released from molecules after absorbing light. Electrons of different 
atoms absorb energy from photons and in turn emit it at different wavelengths 






1.2 Light and photobiology 
 
 
Light/UVR is made up of photons (the smallest available “light packets”) and is 
propagated in the form of waves, so in a sense it is both a particle and a wave. The 
spatial period of the wave as it advances, is defined as wavelength and is measured in 
nanometres (nm). Photons at different wavelengths have different energies; the longer 
the wavelength, the lower the energy. 
 
Photobiology is the science dedicated in studying the effects of light, including UVR, 
either harmful, or beneficial. The significance of photobiology as a discipline is easy to 
appreciate just by looking at the Nobel prizes awarded in the field, starting from the 
early 1900s (Phototherapy of lupus vulgaris and other diseases.), until 2008 (Discovery 
and development of the green fluorescent protein). The importance of photobiology is 
also highlighted by the fact that photobiologists can be found in numerous disciplines, 
varying from physics, biology, medicine and chemistry, to agriculture, ecology and 
meteorology. In addition, photo(chemo)therapy is widely used to treat skin diseases. 
 
1.3 Importance of action spectra and UVR sources 
 
 
Since the biological effects induced by UVR depend on the wavelengths of the radiation 
source, it is necessary to have spectral emission data in order to properly determine the 
hazard. These data consist of spectral irradiance (W/m2/nm) measurements of the 
source, measured with a spectroradiometer. The total irradiance (W/ m2) is obtained by 
summing over all wavelengths emitted. The biologically-weighted irradiance is 
determined by multiplying the spectral irradiance at each wavelength by the biological 
or hazard weighting factor, termed action spectrum (which quantifies the relative 
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efficacy at each wavelength for causing the effect), and summing over all wavelengths 
(Cridland and Driscoll, 2009). All these factors are obtained from action spectra. 
Therefore, it is important for all studies concerned with UVR-induced damage on 
human tissue, to include detailed information about their UVR sources. This would 
enable researchers to replicate experiments easier and compare results in a more robust 
manner. 
 
Another common problem that must be addressed in photobiology is the fact that 
studies often differ in specifying doses based either on physical (spectra/irradiance) or a 
biological (erythemal) basis. 
 
1.4 Ultraviolet radiation and its effects on human health 
 
UVR ranges from 10 nm to 400 nm in the electromagnetic radiation spectrum (Figure 
1.1). UVR is composed of UVA (315-400 nm), UVB (280-315 nm) and UVC (100-280 
nm), based on the official designations of the Commision Internationale de l’ Eclairage 
(CIE). However, in dermatological photobiology, UVR is commonly divided into UVA 
(320-400 nm), UVB (290-320 nm) and UVC (200-290 nm) (Diffey, 2002). Since 
advances in photobiology indicated a clearer distinction between UVB and UVA 
wavelengths, UVA was further subdivided to UVAI (320-340 nm) and UVAII (340-400 
nm). This is because the shorter wavelength UVAII is more like UVB in terms of 
photobiological mechanisms. 
 
From as early as the 1900s, photobiologists had concluded that UVR was important in 
damaging macromolecules and cell nuclei in particular (Bovie, 1918a). In studies in 
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1918, Bovie and Hughes were the first to describe specific UVR-induced alterations in 
the rate of cell growth and demonstrated that nuclear chromatin was particularly 
sensitive. They concluded with the insightful comment that the effects of UVR could be 
determined by energy absorption in molecules (Cleaver, 2002; Bovie and Hughes, 
1918). 
 
Since the skin is the largest human organ, it is constantly exposed to the potentially 
dangerous effects of UVR. Although UVC damages the skin (superficial layers), the 
longer UVR wavelengths, UVB and UVA, are more relevant to human exposures due to 
the elimination of wavelengths below 300 nm by the stratospheric ozone layer 
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The UVR component of the terrestrial solar spectrum comprises approximately 5% of 
the total solar radiation. The majority (>95%) of solar UVR is UVA, and most (~75%) 
of this is UVAI (340-400 nm). This emphasizes the need to study the biological effects 
of UVA. 
 
Although the short- and long-term consequences of solar UVR exposure have been well 
established (Marrot and Meunier, 2008), we lack detailed knowledge of spectral effects 
and their mechanisms, especially with long-term effects. 
 
Exposure of skin to UVR may result in acute and chronic damage. Short-term 
overexposure causes sunburn (erythema), while chronic overexposure leads to an 
increased risk of skin cancer and photoageing (Meewes et al., 2001). In 1992, solar 
radiation was classified by the International Agency for Research on Cancer (IARC) as 
a Group 1 carcinogen, with a well-established link to cutaneous malignant melanoma 
and non-melanocytic skin cancer (World Health Organisation, 1992). UVR has also 
been linked with eye melanoma (Guenel et al., 2001) and non-Hodgkin’s lymphoma 
(Tavani et al., 2006). It is therefore clear that UVR constitutes a great occupational 
hazard, especially in susceptible populations.  
 
Sunlight can also suppress the immune function of skin (immunosuppression) and 
promote skin cancer formation (Streilein et al., 1994). Immunosuppression has been 
demonstrated in all patients with basal or squamous cell carcinomas (Rangwala and 
Tsai, 2011). Most UVR immunosuppression studies have used UVB, but recently UVA 
has been found to also play an important role (Damian et al., 2011; Halliday and Rana, 
2008). One of the most well-studied chromophores, urocanic acid (UCA) (Gibbs and 
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Norval, 2011) has been recognised as an important initiator of the complex cascade 
leading to cell immunosuppression (Kaneko et al., 2008), but its mechanism of action is 
not completely understood (Gibbs et al., 2008). However, there is also evidence that 
DNA damage and the cyclobutane pyrimidine dimer (CPD; see section 1.6) in particular 
is important in immunosuppression (Kripke et al., 1992). In general, the mechanisms of 
UVR-induced immunosuppression still remain unclear (Norval, 2006). 
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The nature of the DNA damage induced by UVR strongly depends on the wavelength of 
the incident photons that reach the cell (Douki et al., 2003). Since an increase in 
wavelength also means an increase in skin and tissue penetration (Bruls et al., 1984; 
Tewari et al., 2012a), the abundance of UVA (and particularly UVAI), in solar UVR 
means that it is very important to study its effects on skin.  
 
During the last 20-30 years UVA attracted great interest, mainly due to its dominant 
role in the cosmetic industry. Sunlamps and sunbeds that are now widely used in the 
UK and other countries use a spectrum particularly high in UVA content. From as early 
as the 70s, tanning devices have been very popular. In 1985, the US Food and Drug 
Association (FDA) approved UVA emitting lamps for use in cosmetic skin tanning. 
UVA radiation was originally thought to cause tanning without any harmful effects to 
the skin. Actually, before 1990, only UVB, and not UVA, was considered to be 
carcinogenic. A lot of progress has been made since then in the understanding of the 
harmful effects of UVA radiation, but artificial tanning still remains a controversial 
subject. Although some older studies failed to demonstrate a clear danger, more recent 
research has established a correlation between sunbed use and skin cancer (Young, 
2004; Gallagher et al., 2005). Furthermore, in 2005, the International Agency for 
Research on Cancer (IARC) assembled a “Working Group” of international experts on 
skin cancer and UVR to review the potential association between sunbed use and skin 
cancer. Meta-analysis of epidemiological data by the Working Group provided evidence 
between exposure to artificial UVR and increased risk of skin cancer, especially 
melanoma in people under 35 years of age (Autier et al., 2011). 
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The major reason UVA has drawn so much attention is that this spectral region 
penetrates the skin deeper than UVB readily reaching beyond the basal layer of the 
epidermis to the dermis, with the potential to damage dermal collagen and elastic fibres 















Figure 1.3: Human skin penetration by UVR 
Approximate depth for UVA and UVB penetration in the human skin is based on a study 
















UVA leads to free radical production, which can modify DNA along with other cellular 
components and may even lead to photocarcinogenesis (Baier et al., 2007; Agar et al., 
2004; de Gruijl, 1995). Reactive oxygen species (ROS) are widely known as mediators 
of UVA-induced photodamage but the exact mechanism of their generation in UVR-
irradiated skin is not fully understood. UVA-induced production of ROS is summarized 
in Figure 1.4a. Although UVA can cause an increase in electron leakage from the 
mitochondrial respiratory chain and enhance ROS production, the most prevalent theory 
about UVA oxidatively-induced photodamage involves photosensitization by 
endogenous chromophores in the human skin (Scharffetter-Kochanek et al., 1997). 
These chromophores absorb photons, reaching a photoexcited state, known as the triplet 
state. The sensitised chromophore can then damage human skin either through direct 
reaction with molecules such as DNA bases (type I photosensitisation; Figure 1.4b I), or 
by reacting with oxygen (type II photosensitisation; Figure 1.4b II), leading to free 
radical formation (Wondrak et al., 2006). UVAI, a particularly potent inducer of 
oxidative stress (Phillipson et al., 2002) has been found to induce the generation of 
singlet oxygen (1O2), which causes skin ageing and cancer, and is an established 
mediator of photodamage (Baier et al., 2007; Davies, 2004). 
 
1O2 is an excited state molecule that is formed by direct energy transfer between the 
excited sensitizer and ground state triplet oxygen, as illustrated in Figure 1.4 (reaction II 
A). Formation of the superoxide radical anion (O·2-), as a precursor of hydrogen 
peroxide (H2O2) occurs through electron transfer, giving rise to a sensitizer radical 
cation (reaction II B), or after intermediate reduction of the sensitizer by a substrate 





Figure 1.4a:  UVA-induced oxidative stress 
 
After UVA absorption, the excited photosensitizer (S*) generates 1O2, which plays a key 
role in UVA-induced ROS production; The high redox potential of 1O2 allows it to react 
with all major classes of biomolecules, leading to protein oxidation, lipid 
peroxidation and DNA damage, and it triggers the generation of other ROS. 
 
                       
 
Figure 1.5b: Photosensitization reactions type I and type II 
Photon absorption by chromophores in the electronic ground state (S) induces 
formation of photoexcited states (S*). These can interact directly with substrate 
molecules (R), like DNA bases (type I reaction) or activate molecular oxygen by 
electron or energy transfer reactions (type II reactions). Adapted by Wondrak et al 
(Wondrak et al., 2006) 
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As mentioned above, UVA can cause direct and indirect DNA damage, and its 
mutagenicity has been attributed to oxidatively generated modification of DNA 
nucleobases (Kassam and Rainbow, 2009). One of the most intensively studied lesions 
is the guanine-derived lesion 8-oxo-7,8-dihydroguanine (8-oxoGua), and its 
corresponding base, 2’-deoxyribonucleoside, 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-
oxodGuo) (Figure 1.5). This lesion is a possible cause of UVA mutagenesis, and its 
presence has been studied in both human DNA and urine (Kappes et al., 2006; 
Kielbassa et al., 1997; Cooke et al., 2001).  
 
Several studies have focused on the activation of mitogen-activated protein kinases 
(MAPK) through UVA-induced ROS, and mainly through singlet oxygen (Bachelor and 
Bowden, 2004). Down-stream of MAPK and other signalling cascades, UVA irradiation 
has also been shown to activate various transcription factors such as AP-1 and NFκB, 
affecting crucial pathways involved in carcinogenesis (Reelfs et al., 2004; Wu et al., 
2008). Furthermore, UVA induces the expression of several genes such as heme 
oxygenase 1 (HO1), matrix metalloproteinase 1 (MMP1) and tumour necrosis factor α 
(TNFα), that are also involved in photocarcinogenesis through immunosuppression or 
the degradation of extracellular matrix proteins (Klotz et al., 2003; Wondrak et al., 
2006). It has also been proposed that UVA may increase intracellular oxidative stress 










Figure 1.6: Chemical structures of 8-oxoGua and its corresponding base, 8-oxodGuo 
Designed with ChemDraw Ultra 
 
 
8-oxoGua has been used in various studies as a biomarker of oxidatively induced DNA 
damage. It is mostly repaired by the base excision repair (BER) pathway and is 
specifically recognized by the formamidopyrimidine glycosylase (Fpg) in Escherichia 
coli and the human oxoguanine glycosylase 1 (hOGGl) protein in humans (Girard and 
Boiteux, 1997). 
 
In general, mutations by UVA-induced DNA damage typically consist of T-G 
transversions, called "UVA fingerprint" lesions (Agar et al., 2004). Furthermore, UVA 
has been shown to induce fewer immediate mutations than UVB, but more long-term 
mutations (“delayed mutations”) (Dahle and Kvam, 2003). UVA-induced mutations 
have been reported by various workers (Huang et al., 2009; Mitchell and Fernandez, 
2012). Evidence also exists showing that indirect oxidatively-induced DNA damage due 
to UVA, may promote melanoma formation (Panich et al., 2011; von Thaler et al., 
2010). Recent epidemiological data also strengthen the link between UVA and 




For many years, it was thought that UVB was far more carcinogenic to the skin than 
UVA. Of course, when comparing similar physical doses between the two, UVB 
radiation is much more damaging. This is because UVB is highly mutagenic and is 
directly absorbed by macromolecules such as proteins, lipids and DNA (Marrot and 
Meunier, 2008). UVB-induced DNA damage has therefore been considered as a key 
factor leading to mutations in genes associated with cancer, hence initiating the 
formation of tumours. UVB has also been found to induce genomic instability (an effect 
shared with UVA), and it can also cause delayed mutations (Dahle et al., 2005). 
 
UVB radiation has been shown to give rise to dimeric photoproducts between adjacent 
pyrimidine bases. Two major types of these modifications are produced, known as 
cyclobutane pyrimidine dimers (CPD; Figure 1.6) and pyrimidine (6-4) pyrimidone 
photoproducts (6-4 PP) (Mouret et al., 2006; Marrot and Meunier, 2008). 6-4PP may 
change into an isomeric secondary product, the Dewar valence isomer, after subsequent 
absorption of UVA (Matsunaga et al., 1991; Chadwick et al., 1995). The role of these 
dimeric lesions in carcinogenesis may be due to high proportion of p53 mutations, 
mostly C to T and CC to TT transitions, detected at bipyrimidine sites in skin tumours 
(Mouret et al., 2008).  
                              




As mentioned previously, UVR produces specific DNA damage, and the CPD is one of 
the most important and well-studied photolesions. UVR causes the formation of CPD 
and 6-4PP at dipyrimidine sites, where two pyrimidine bases are juxtaposed in tandem 
in the nucleotide sequence of DNA. These photolesions are formed through a 
photochemical reaction, whose efficiency is wavelength-dependent, following direct 
absorption of UVR by DNA bases (Markovitsi et al., 2004). 
 
The importance of CPD is highlighted by the recent conclusion that they are the 
principal lesion responsible for most DNA damage-dependent biological effects of solar 
UVR (Besaratinia et al., 2011). CPD, 6-4PP and also the Dewar isomer, cause UVR-
specific mutations. Specifically, UVR-induced CPD formation can lead to non-
melanoma skin cancers (You et al., 2001), since they may strongly contribute to the 
mutation spectrum in the p53 gene of non-melanoma skin cancers (Pfeifer and 
Besaratinia, 2012). 
 
However, CPD also have non-mutagenic consequences such as initiating cytokine 
release (Wolf et al., 2000) and photoimmunosuppression, which is thought to be 
important in skin cancer (Halliday, 2005; Walker and Young, 2007). They have also 
been associated with the induction of matrix metalloproteinase-1 (MMP1) which may 
play a major role in photoageing (Dong et al., 2008). CPD are readily induced by direct 
absorption of UVB (as well as UVC) by DNA, and are thought to be an important 




A noteworthy observation was the fact that DNA pyrimidines’ absorbance spectrum 
overlaps with the UVB spectral range. This means that pyrimidines can act themselves 
as chromophores (Sage, 1993). The importance of pyrimidine photolesions is outlined 
by the fact that CPD and 6-4 PP are the most abundant DNA lesions in epidermal cells 
following UVB radiation (Clingen et al., 1995; Young et al., 1996). It is now known 
that, in mammalian cells proficient in DNA repair, the vast majority of UVB-induced 
mutations are caused by CPD. In general, bipyrimidine photoproducts are repaired by 
nucleotide excision repair (NER). However, when left unrepaired they can form the 
classic ‘‘UVB signature’’ mutations that require the methylation of cytosines (C→T or 
CC→TT) and lead to various skin cancers (Rochette et al., 2009; Ziegler et al., 1996). 
 
1.5.1 UVA-induced CPD 
 
During the last 10-15 years, a lot of focus has been drawn to the production of CPD due 
to UVA irradiation. Since recent in vitro and ex vivo studies have drawn attention to the 
fact that UVAI can readily induce the formation of CPD, especially of thymine dimers 
(T<>T) (Mouret et al., 2006; Jiang et al., 2009; Mouret et al., 2010), the mechanisms by 
which these photolesions are produced, has been a matter of considerable debate (Douki 
et al., 2003). In a 1999 study, Douki and his colleagues observed the production of 
UVA-induced CPD. They hypothesized that CPD could be formed in cellular DNA in 
part by photosensitization by endogenous chromophores upon UVA irradiation (Douki 
et al., 1999). Unlike UVB, UVA (and particularly UVAI) induces the production of 
thymine dimers (T<>T), but very few C<>C, C<>T, and no 6-4PP. At first, an indirect 
photosensitized triplet energy transfer mechanism with UVAI was suggested to explain 
the high yield of UVA-induced CPD (Cadet et al., 2009; Mouret et al., 2006). However, 
 36
the latest research has indicated that this may not be the case. CPD formation (and 
specifically T<>T) is now thought to be a direct photochemical mechanism, without any 
involvement of endogenous photosensitizers (Jiang et al., 2009; Mouret et al., 2010). 
This –now reported- CPD formation by direct absorption had been hinted as early as 
1981, based on the weak absorption of DNA in the UVA region (Sutherland and Griffin, 
1981). 
 
Another interesting point to notice is the lack of 6-4PP formation following UVA 
irradiation. This suggests that the photochemical process is different from that with 
UVB and UVC wavelengths, but this difference remains to be elucidated. 
 
An interesting observation from some studies using quantitative techniques, has been 
that UVA-induced CPD are produced in larger amounts than 8-oxoGua in human skin 
and in primary cultures of human cutaneous cells (Courdavault et al., 2004; Mouret et 
al., 2006). Recent studies also concluded that UVA-iduced CPD formation is similar for 
keratinocytes and melanocytes, but suggested a cell-specific preference for UVA-
induced 8-oxoGua, which was more prominent in melanocytes (Mouret et al., 2012). 
However, discrepancies in the UVA-induced mutation spectrum among various research 
groups might result from differences in the UVA sources and doses used (Ikehata and 
Ono, 2011).  
 
Although recent findings contradict a direct involvement of ROS in UVA-induced CPD, 
there is evidence suggesting a key role in their formation. Protection offered by certain 
antioxidants against CPD formation could mean an indirect role of ROS in causing 
damage to DNA repair enzymes or halting repair processes through other mechanisms 
(Hochberg et al., 2006; Halliday, 2010). 
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1.6 DNA repair 
 
The biological significance of UVR-induced DNA lesions depends on the capacity of 
the cell to repair the damage caused, before it can permanently affect the human 
genome. Research on xeroderma pigmentosum (XP) patients (a disease characterized by 
a deficiency in repairing UVR-induced DNA damage) (Moriwaki and Kraemer, 2001) 
has been a key factor in understanding how direct DNA damage by UVR may cause 
skin cancers.  
 
The major system responsible for repairing UVR-induced DNA damage in human cells 
is NER (Friedberg, 2001). NER is an extremely accurate process that repairs damaged 
nucleotides (such as CPD and 6-4PP) by excising the damaged area, leaving a single 
strand gap of about 25-30 nucleotides. Then, the opposite –undamaged- strand is used 
as a template for resynthesis of the gap by DNA polymerase (de Gruijl, 1999). The 
overall process in humans is quite complex and involves more than twenty proteins. 
Briefly, the NER system is divided in two subpathways: the global genome NER (GG-
NER), which continuously surveys the entire genome for distorting damage, and the 
transcription-coupled repair (TCR) that focuses on damage that blocks the activity of 
elongating RNA polymerases (Hoeijmakers, 2001). The importance of NER is 
evidenced by the severe disorders occurring in the event of certain genetic mutations, in 
which NER is compromised. Consequences of such defects result in three rare recessive 
syndromes: XP, Cockayne syndrome (CS) and the photosensitive form of the brittle hair 
disorder trichothiodystrophy (TTD) (de Boer and Hoeijmakers, 2000; Kraemer et al., 
2007). In conclusion, a deficiency of the DNA repair mechanisms may lead to an 
accumulation of mutations over time and increase the risk of skin cancer development 




The increasing incidence of skin cancer in sun-sensitive, white-skinned populations has 
initiated much discussion and research on acute and long-term photoprotection. 
Sunscreens have limitations (Diffey, 2009) and consequently other methods of 
photoprotection have been sought. These include the use of antioxidants, although it has 
often been difficult to prove their efficacy for protection of human skin in vivo 
(Cocheme and Murphy, 2010). 
 
In general, sunscreen formulations contain a mix of chemicals that are applied to the 
outer layer of the human skin. These chemicals act by absorbing or reflecting UVR. 
Sunscreens are labelled by their sun protective factor (SPF), which is a measure of their 
ability to prevent erythema after a single exposure to solar simulating radiation (SSR). 
Recent developments in our understanding of UVA-induced damage to the human skin 
have increased the necessity of producing better sunscreens, more potent in attenuating 
UVA radiation.  
 
1.7.1  Sunscreens 
 
 
Protection against UVR has been a major concern since the harmful effects of sunlight 
became known. In the past, sunscreens focused in the protection against the UVB 
portion of solar UVR, but during the recent years formulations have been optimized to 
become protective over a broader spectrum of UVR and maintain greater photostability 
(Morabito et al., 2011). Sunscreens are comprised of organic and inorganic compounds 
that act as shields against UVR. Organic components act as chemical sunscreens by 
absorbing UVR. In contrast, inorganic components act as physical sunscreens by 
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absorbing, reflecting, or scattering UVR. Sunscreen is applied topically to the skin, 
covering the dead stratum corneum, protecting the skin’s multiple living layers. 
 
A problem that has been highlighted lately in the photobiology community is that SPF is 
an incomplete measure for protection of sunscreens, as it is primarily dependent on 
UVB protection and does not adequately illustrate UVA protection offered by the 
product (Bissonnette, 2008). Recently, other indicators to assess protection against non-
melanoma skin cancers and to quantify the effectiveness of sunscreens against UVA, 
such as the UVA-protection factor (UVA-PF) have been proposed (Couteau et al., 2011; 
Fourtanier et al., 2011). 
 
As oxidative stress and its effects on the human skin are implicated in photodamage, 
several antioxidants have been tested and incorporated in sunscreens, once it was 
demonstrated that they can be delivered into the skin percutaneously. Beneficial effects, 
among other compounds, have been shown for vitamins C and E and β-carotene that 
have been found to reduce erythema (Edlich et al., 2004). However, it has been stressed 
that prevention of erythema cannot guarantee the prevention of epidermal DNA 
photodamage (Young et al., 1998). Epidemiological studies have also shown that 
sunscreen use can protect against actinic keratoses, squamous cell carcinoma (SCC), 
and indeed melanoma (Green et al., 2011; Green et al., 1999; Thompson et al., 1993). 
 
In general, recent evidence supports the use of non-sunscreen materials such as 
botanical extracts, antioxidants, and DNA repair enzymes in sunscreen lotions, as they 
can add value to the product when applied topically to human skin (Matsui et al., 2009; 
Oresajo et al., 2010). 
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1.8 Positive effects of UVR 
  
 
One of the most important substances necessary for the human organism is vitamin D. 
Nature has provided humans with two sources to acquire this essential nutrient: solar 
UVB radiation and diet. Since most foods provide very little vitamin D (with one 
exception being oily fish), especially in typical Western diets, solar UVB radiation is 
necessary to obtain vitamin D (Young, 2010). Various studies have shown vitamin D 
deficiencies in people living in sun-deprived locations (or even sunny places). 
Manmade interventions to bypass this issue include food fortification, supplementation, 
and the use of tanning devices with UVB. 
 
One of the most important functions of vitamin D is to maintain blood calcium levels 
within the normal range in order to maintain neuromuscular function and bone 
mineralization. During the past few decades, intensive research on vitamin D has 
revealed that vitamin D is a hormone and not a vitamin. During exposure to sunlight 
provitamin D in the skin is photolyzed to previtamin D, a thermally labile intermediate 
that slowly -thermally- converts to vitamin D. Once formed, vitamin D enters the 
circulation and is hydroxylated first in the liver to 25-hydroxyvitamin D (25-0H-D) and 
then to the kidney to form the biologically active form 1,25-dihydroxyvitamin D (Webb 
and Holick, 1988). There are two major forms of vitamin D: vitamin D2 (ergocalciferol) 
and vitamin D3 (cholecalciferol). The former, results from UVB irradiation (280-320 
nm) of a yeast sterol, ergosterol (provitamin D2), the latter from irradiation of 7-
dehydrocholesterol (provitamin D3), a sterol that is naturally present in skin cells.  
 
The dermatological community is now aware of the well-established detrimental effects 
of UVB. Although researchers are also aware of the role of UVB radiation in vitamin D 
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synthesis and the health benefits it offers, they are concerned about the misuse of 
information given to the public aiming for financial gain in a field which could be 
proven to be quite profitable. Therefore, much work remains to be done in risk-versus-
benefit assessment of UVR exposure (Young, 2010). 
 
1.9 Oxidative stress 
 
The generation of ROS in the skin results in oxidative stress when their concentration 
exceeds the antioxidant defense ability of the target cell. Oxidative stress is defined as 
an imbalance between pro-oxidants and antioxidants in favour of the former (Jones, 
2006). Oxidative stress is produced by a variety of reactive oxidants. ROS are short-
lived and are continuously generated at low levels as the consequence of normal aerobic 
metabolism. In general, they are oxygen-centered radicals (free radicals) that contain an 
unpaired electron. Some of the most important ROS involved in biological processes are 
the superoxide anion (O·2-), singlet oxygen (1O2) and hydrogen peroxide (H2O2). ROS 
are also produced in phagocytic cells, mainly through the activation of NADPH 
oxidase, while they attack various pathogenic agents (Bickers and Athar, 2006; Jones, 
2006). UVR induces various ROS in human cells, including hydrogen peroxide, 
superoxide anion, singlet oxygen, and hydroxyl radical (Scharffetter-Kochanek et al., 
1997). 
 
Oxidative stress is involved in ageing and plays an important role in the 
pathophysiology of several diseases, among which are cancer, vascular disorders, as 
well as degenerative diseases. Furthermore, it is now known that oxidative stress has a 
big impact on intracellular signaling processes (Kim et al., 2005; Reelfs et al., 2004).  
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1.9.1 Measurement of oxidative stress 
 
The study of the effects of oxidative stress requires methods for its measurement, 
particularly in vivo. Due to their high reactivity and limited lifetime, the detection of 
free radicals in vivo is still difficult, and techniques able to directly assess ROS in 
human tissue are still scarcely available. Therefore, the majority of techniques 
developed so far are based on the detection of the end products resulting from the 
reactions of free radicals with several biomolecules (Milatovic et al., 2011). Until now, 
considerable effort has been made to validate these assays, but still it is not clear which 
is most suitable for routine clinical assessment of oxidative stress.  
  
Oxidative stress assays include detection of antioxidant enzyme systems, small 
molecule antioxidants, antioxidant/oxidant balance, reactive oxidants, and products of 
oxidative damage. On the pro-oxidant side of the balance, assays are available to 
measure ROS and products of lipid peroxidation, protein oxidation, and DNA damage. 
Free radicals can be measured by spin-trapping and electron spin resonance (ESR) 
spectroscopy (Valgimigli et al., 2001), but these methods are not considered suitable for 
clinical studies. However, a more recent study with new in vivo ESR techniques, has 
shown that it is now feasible to carry out human studies in vivo to get valuable 
information on effective UVR protection (Herrling et al., 2006). On the other hand, a 
simple colorimetric assay to measure preformed reactive species in the blood has been 
developed. It provides a rapid and sensitive way to quantify oxidants that react with 
phenylenediamine and it could prove extremely helpful at on-site screening of 




Some of the most popular assays are those measuring products of lipid peroxidation 
(Bartsch and Nair, 2000). They can measure specific hydrocarbons (by means of gas 
chromatography, or mass spectrometry) such as ethane and F2 isoprostanes (Roberts 
and Morrow, 2000), or aldehyde products (thiobarbituric acid reactive substances assay, 
TBARS). 
 
Other techniques, like antibodies targeted against oxidative lesions, high performance 
liquid chromatography (HPLC) and enzyme-linked immunosorbent assay (ELISA), 
have been used to measure oxidative DNA damage. HPLC has been shown to be very 
accurate in the detection of 8-oxodGuo (Marrot and Meunier, 2008; Cooke et al., 
2008b). 
 
From the antioxidant aspect, several assays are available. These are able to measure 
intracellular concentration of antioxidants such as vitamin C or E, as well as the activity 







Cells are equipped with antioxidant defensive mechanisms that can either act by 
preventing ROS formation, or by eliminating them. This defense system includes 
various enzymes such as superoxide dismutase (SOD), catalase (CAT) and glutathione 
peroxidases (GPx), as well as some non-enzymatic antioxidants like glutathione 
(Remacle et al., 1992). A broad definition of an antioxidant was given by Halliwell and 
Gutteridge, as “any substance that, when present at low concentrations compared with 
those of an oxidizable substrate, significantly delays or prevents oxidation of that 
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substrate” (Halliwell and Gutteridge, 1999).  The purpose of antioxidants is to protect 
cells from the harmful effects of free radicals, which have been found to damage cells 
and molecules and have been implicated in cancer and numerous diseases (Dreher and 
Junod, 1996; Cross et al., 1987). Since ROS are a constant threat, either produced in the 
human organism, or through environmental exposures such as UVR, air pollution and 
cigarette smoke, antioxidants are necessary to protect cells from their damaging effects, 
and therefore, have always been an appealing research topic (Kelly, 2004; Doruk et al., 
2011). 
 
Since epidemiology has pointed towards the use of antioxidants as the active ingredients 
of fruits and vegetables, several compounds have been employed in cancer research, 
heart diseases, and many other complications arising from an increased oxidative stress 
in the human organism. During the last two decades, many antioxidant supplementation 
trials have been conducted. The results have usually been controversial, and most 
studies could not provide definite evidence that antioxidant supplementation is actually 
beneficial (Collins and Horváthová E, 2001; Slatore et al., 2008). Even negative 
outcomes have been observed; one study suggested that -carotene supplementation 
increased lung cancer incidence in a group of smokers (The Alpha-Tocopherol Beta 
Carotene Cancer Prevention Study Group, 1994). However, some studies have shown 
that antioxidants might be beneficial in cancer patients, increasing tumour response to 
chemotherapy, and reduce toxicity, or even increase survival (Simone et al., 2007; Block 
et al., 2007). 
 
Antioxidants have been employed for trials on many diseases in which oxidative stress 
is implicated. A recent study on pulmonary tuberculosis showed that vitamin E and 
selenium supplementation can reduce oxidative stress and enhance total antioxidant 
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status in patients suffering from the disease (Seyedrezazadeh et al., 2008). On the other 
hand, most trials dealing with atherosclerosis have concluded that antioxidants do not 
have a supportive role in its chronic suppression (Steinhubl, 2008). Vitamins C and E 
have been extensively used in an effort to prevent pre-eclampsia, a disease occuring 
during pregnancy. Data from these studies have been controversial, but overall, 
antioxidant supplementation has not been found to reduce the risk of the disease 
(Padayatty et al., 2006; Rumbold et al., 2008). 
 
These examples demonstrate the status of antioxidant trials until today, but also 
highlight the need to understand the reasons behind the failure of clinical trials to 
exhibit a clear benefit of antioxidant therapies. 
 
1.10.1 Antioxidants against UVR-induced oxidative stress 
 
All major antioxidant enzymes as well as low molecular weight antioxidants are present 
in the human skin (Shindo et al., 1994). Antioxidant capacity of the human epidermis is 
far greater than that of the dermis, presumably because it is exposed to higher doses of 
UVR, but also because it is a much more cellular tissue. In the human epidermis, for 
example, levels of vitamin C (L-ascorbate) are approximately five times higher than in 
the dermis (Fuchs, 1998).  
 
Overall, a complex antioxidant system provides protection to human skin from photo-
oxidative stress. It has been well-established that UVR depletes the skin’s natural 
antioxidant system (Podda et al., 1998). If antioxidant defenses fail along with cellular 
repair systems, cells are led to apoptosis (programmed cell death). Both UVA and UVB 
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may induce apoptosis in human cell lines (Godar, 1996), although the exact mechanism 
of UVR-induced apoptosis is not entirely understood. Most of the work that 
demonstrates the efficacy of antioxidants has been carried out in vitro. There are 
surprisingly few data that unequivocally demonstrate the efficacy of antioxidants in 
human skin in vivo (Bickers and Athar, 2006). 
 
A study in 2001 found that topically applied vitamin C slightly enhanced levels of 
mRNA for procollagens I and III; it also enhanced levels of some procollagen 
processing enzymes in human skin (Nusgens et al., 2001). The outcome was quite 
interesting, but there are some doubts whether the technique used in the study was able 
to detect the minor changes reported (Pinnell, 2003). A 2002 trial, employing 8 
volunteers, examined the effects of vitamin C supplementation prior to UVR (McArdle 
et al., 2002). No evidence showing any effect of the supplementary vitamin C on the 
mild oxidative stress seen in the human skin was obtained. In contrast, a reduction of 
total glutathione and protein thiols was observed, probably indicating the replacement 
of some reductants in cells by the supplemented antioxidant. Very recently vitamin C 
was found to protect against UVA-induced melanogenesis, possibly by 
boosting antioxidant defense capacity and inhibiting nitric oxide (NO) production 
(Panich et al., 2011). 
 
Many photoprotecion studies have focused on the use of carotenoids, as they exhibit 
specific antioxidant activity but also influence gene expression. β-Carotene and 
lycopene are two of the most studied compounds of this group, and have been found to 
protect the skin against UVR-induced erythema (Stahl and Sies, 2012; Rizwan et al., 
2011). 
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Several studies have documented the photoprotective effects of topically applied 
vitamin E (-tocopherol), but all were conducted on animal skin (Burke et al., 2000; 
Lopez-Torres et al., 1998). On the other hand, an oral combination of vitamins C and E 
in high doses protects against UVR-induced erythema in human beings, while either 
vitamin alone is not effective (Fuchs and Kern, 1998; Eberlein-Konig et al., 1998). 
Furthermore, a recent human trial combining vitamins C and E with ferulic acid 
(possibly acting as a stabilizer), found a substantial protection against acute UVR injury 
(Murray et al., 2008). The authors proposed that the p53 pathway (induced by UVR, 
and may lead to DNA repair, cell cycle arrest or apoptosis) is implicated in the outcome 
of their study, as the antioxidant mixture used reduced p53 activation.  
 
Another in vivo study was conducted in 2004 and tested the effects of oral vitamin E 
and -carotene supplementation on 16 healthy subjects, following UVR (McArdle et al., 
2004). Neither of the supplements was able to provide protection from UVR-induced 
oxidative stress. A more recent in vivo study showed that a combination of tocopherols 
and tocotrienols reduced UVB-induced erythema in human volunteers (Pedrelli et al., 
2011). 
   
Green tea polyphenols have also been suggested as possible photoprotective agents, and 
animal studies have exhibited their antioxidant capacity (Pinnell, 2003). A human trial 
in 2001, showed a protective effect on human skin (Elmets et al., 2001). Skin pretreated 
with green tea polyphenols before UVR exposure, developed less erythema in 
comparison to untreated skin. Unfortunately this study did not assess the levels of 
oxidative stress. Another polyphenol, luteolin, was very recently found to protect 
human skin against UVB-induced CPD. Its protection was attributed to a combination 
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of UVR-absorbing, DNA-protective, antioxidant, and anti-inflammatory properties 
(Wölfle et al., 2011).  
 
Several antioxidants have also been found to protect against photoimmunosuppression 
(Steenvoorden and van Henegouwen, 1997). Lutein (a carotenoid) has been shown to 
decrease UVB-induced immunosuppression (Lee et al., 2005), while lycium barbarum 
was shown to protect against solar-simulated UVR-induced immunosuppression in 
mouse skin (Reeve et al., 2010). Recently, the phytoestrogenic isoflavonoid equol was 
found to protect against UVA-induced immunosuppression in mouse skin (Widyarini et 
al., 2012). 
 
An important –and poorly addressed- issue in antioxidant studies is the fact that many 
of the compounds tested absorb in the UVR region. This makes it difficult to determine 
if their protective effects are attributed to their antioxidant or to their spectral properties. 
In general, the photoprotection offered by antioxidants alone would be the equivalent of 
a weak sunscreen with a maximum SPF of 4; however the combination of antioxidants 
with traditional susnscreens has been able to provide SPF levels of about 30 (Baran and 
Maibach, 2004). 
 
1.11 Vitamin E 
 
Since a significant part of this thesis has dealt with vitamin E, an introduction in this 
potent antioxidant is necessary.  
 
Vitamin E is a lipid-soluble antioxidant that can be found naturally in some foods (such 
as peanuts, sunflower seeds and almonds) but is also widely available as a dietary 
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supplement. Vitamin E includes a family of tocopherols and tocotrienols that share a 
chain-breaking antioxidant activity. Tocopherols and tocotrienols exist in eight chemical 
forms (four for each “family”): α-, β-, γ -, and δ. These forms differ in the number of 
methyl groups on the chromanol aromatic ring. Tocopherols have a phytyl tail, whereas 
tocotrienols have an unsaturated tail (Brigelius-Flohe, 2006). However, notably, α-
tocopherol (Figure 1.7) is the only form of vitamin E that meets human requirements 
and is capable of reversing deficiency symptoms in humans. The biochemical reason for 





Figure 1.8:      Chemical structure of α-tocopherol 
 
Vitamin E is available commercially, both as a natural or a synthetic preparation.  
Naturally occurring α-tocopherol is referred in the literature as RRR- α-tocopherol, or d- 
α-tocopherol. Synthetic α-tocopherol is referred to as all-rac-α-tocopherol, or dl- α-
tocopherol. The esterified forms of vitamin E such as α-tocopherol acetate, α-tocopherol 
succinate and α-tocopherol nicotinate are also available commercially. 
 
For simplicity’s sake, α-tocopherol from now on, in the rest of the presented thesis, will 
be referred as vitamin E. 
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Serum concentrations of vitamin E depend on the liver, which absorbs the nutrient after 
the various forms are absorbed from the small intestine. Vitamin E is transported in 
plasma lipoproteins, and the mechanisms of lipoprotein metabolism determine the 
delivery of vitamin E to tissues. 
 
Vitamin E is considered as nature’s most effective antioxidant and is the major chain-
breaking antioxidant in body tissues. It presents the first line of defence against lipid 
peroxidation and protects cell membranes from ROS (Vasavi et al., 1994). The 
antioxidant activity of α-tocopherol derives from the free hydroxyl group on the 
aromatic ring (Figure 1.8). The hydrogen of the aromatic ring is donated to the free 
radical, giving rise to a relatively stable tocopheryl free radical, which can then in turn 
combine with another peroxy free radical (Kamal-Eldin and Appelqvist, 1996).  
 
Individuals with plasma concentrations less than 0.5 mg/dL are considered vitamin E-
deficient. According to the Food and Nutrition Board of the Institute of Medicine 
(Washington DC, USA) in 2000, daily dietary vitamin E intakes of about 15 mg in 
healthy are sufficient to maintain serum vitamin E concentrations in the normal range 
(Krinsky et al., 2000). 
 
Since free radicals have long been implicated in carcinogenesis, vitamin E has been the 
focus of numerous studies examining its effect as an anti-carcinogen.  
 
Some studies have also demonstrated a protective effect of vitamin E against esophageal 
and oral cancers in mice and hamsters (Odeleye et al., 1992; Trickler and Shklar, 1987; 
Shklar et al., 1990). However, most of the studies have failed to provide conclusive 
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evidence. In contrast, epidemiological data showed no effect of vitamin E against lung 
cancer (The Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994). 
There have often been inconsistent outcomes about the effects of vitamin E supplements 
against lipid peroxidation in in vivo studies, with some failing to show an effect and 
others showing a decrease, or even an increase in lipid oxidation; furthermore, it is still 
not clear to what extent vitamin E supplementation has been successful in raising tissue 
vitamin E levels (Kelly et al., 2004). Also, vitamin E protection levels, exhibit a large 
variation depending on experimental models. A very recent trial connected vitamin E 























1.12 Aims of thesis 
 
 
The significance of UVR-induced oxidative stress and its related complications can be 
appreciated by the fact that publications including these terms increased dramatically in 
the last decade. From 2001, until 2011, 952 articles were published on this (broad) field, 
compared to the previous decade that 347 articles were produced (based on a combined 
search on NCBI Pubmed). Therefore, it is important to shed light on the mechanisms 
that control the extent of UVR-induced damage.  
 
The main aim of this project was to develop a panel of reliable and quantitative methods 
to measure UVR-induced oxidative stress and DNA damage in skin cells in vitro. The 
ultimate aim would be to develop techniques that could be applied to the human in vivo 
situation to test the benefits of antioxidants. More specifically, the goals of the thesis 
were to: 
 
(a) Identify in vitro techniques to measure DNA damage that could be translated 
to human skin in vivo. This was done with a modified comet assay using DNA 
repair enzymes, in order to establish a method of assessment of specific UVR-
induced DNA damage. 
 
(b) Identify UVR-induced genes that could be used in vitro and in vivo. 
 
(c) Evaluate the effects of vitamin E, as a model antioxidant, in decreasing UVR-
induced intracellular ROS, DNA damage and gene expression. 
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(d) Try to differentiate between antioxidant effects and possible sunscreen effects 
of agents tested. 
 
(e) Develop an understanding of the mechanisms of UVA-induced DNA damage. 
 
(f) Test antioxidant compounds supplied by Stiefel laboratories and assess their 
effect against UVR-induced DNA damage and the formation of free radicals. 
 
Considerable attention was given to the spectral properties of the UVR sources used in 






































































Tables 1-5 below list the consumables. All materials/reagents were purchased from the 
UK, unless otherwise specified. 
























































































TaqMan Gene expression assays/PCR mastermix 
 

































































Anti-thymine dimer mAb, clone KTM53 
 
Kamiya Biomedical, USA 
 
Goat anti-mouse immunoglobulin horse radish 













Human oxoguanine glycosylase 1 (hOGG1) 
 
New England Biolabs 
 








T4 endonuclease V (T4endoV) 
 
New England Biolabs 
 
 










































10X Comet assay enzyme reaction buffer 
 
9.5 g Hepes, 7.4 g KCl, 186 mg 
EDTA, 200 mg BSA,  
pH 8, diluted in ddH20 
 
Comet assay electrophoresis buffer 
 
NaOH 10 M, EDTA 200 mM, 
  
pH >13, diluted in ddH20 
 
Comet assay lysis buffer 
 
2.5 M NaCl, 100 mM EDTA, 10 mM 
acid Tris, 1% sodium sarcosinate, pH 
10, 1% of Triton 100, and 10% DMSO 
 
Comet assay neutralization solution 
 




Table 2.6:  Optical properties of antioxidant compounds and their solvents used in thesis 
 
Compound λmax (nm) Solvent 
α-tocopherol (vitamin E) 295 EtOH 
N-acetyl-cysteine (NAC) 215 PBS 
Farnesol 215 DMSO 
Guggulsterone 285 DMSO 












2.2 Cell culture and antioxidant treatments 
 
All cell lines used in the project were routinely tested to assess the absence 
of Mycoplasma infection by 4'-6-Diamidino-2-phenylindole (DAPI) staining. 
 
2.2.1 HaCaT keratinocytes 
 
The spontaneously transformed human keratinocyte cell line HaCaT (abbreviation for 
Human adult low Calcium Temperature) was the main cell line used in the project. This 
cell line is known to bear two p53 point mutations and it is unclear whether p53 in 
HaCaT cells is still functional. HaCaT keratinocytes (originally purchaced from ATCC, 
USA) were routinely cultured in Dulbecco modified eagle medium (DMEM; Invitrogen, 
Paisley, UK) supplemented with 10% foetal calf serum (Sigma-Aldrich, Poole, UK), 
100 U/mL penicillin, and 100 μg/mL streptomycin (Invitrogen) and maintained at 37C 
in a humidified incubator with 95 % air/5 % CO2. For all experiments, cells were 
cultured to 80% confluence in 25 cm2 or 75 cm2 plastic flasks (Corning, USA).  
 
2.2.2 Primary human skin fibroblasts 
 
Human dermal fibroblast cultures (named NH22 for convenience purposes, after the 
name and age of the individual they were acquired from) were established by outgrowth 
from an upper non-previously sun-exposed buttock biopsy of a healthy donor (skin type 
I-II). NH22 fibroblasts were passaged each week (ratio 1:2) in DMEM, supplemented 
with 10% heat inactivated fetal calf serum and 100 U/ml penicillin and 100 g/ml 
streptomycin and maintained at 37C in a humidified incubator with 95% air/5% CO2.  
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Culture media were replaced every three days. All experiments were carried out 
between passages 3 and 14, at the same cell density, i.e., about 70% confluence. 
 
2.2.3 MRC5V1 fibroblasts 
 
For some comparative studies, the SV40-transformed human fibroblast cell line 
MRC5V1 was used. MRC5V1 cells were routinely cultured in DMEM, supplemented 
with 10% FCS, 100 U/mL penicillin, and 100 μg/mL streptomycin and maintained at 




UVR absorbance properties of the various compounds studied, were determined with a 
























2.4 Antioxidant treatments 
 
2.4.1   Vitamin E 
 
Cells were either pretreated for 24h prior to UVR or treated for 2h after UVR, with 0.1 
mM vitamin E (-tocopherol, Sigma). Following pilot investigations with a range of 
vitamin E concentrations from 0.1 to 1 mM, a concentration of 0.1 mM was chosen to 
provide maximal protection against UVA exposure with minimal cytotoxicity. As stock 
solutions of vitamin E were diluted in 100% ethanol (following filter sterilisation with 
0.2 μm pore-size filters), the concentration of ethanol in the medium was 1% and 
therefore controls were also treated with 1% ethanol. In the case of pretreatment, the 
media containing vitamin E were removed and each sample was washed three times 
with Dulbecco’s phosphate-buffered saline (PBS; Sigma) to remove any traces of 
extracellular vitamin E before irradiation. The absorption spectrum of vitamin E is 
shown in Figure 2.1. 
 
 
Figure 2.1: Absorption spectrum of vitamin E (0.1 mg/ml in n-hexane) 
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2.4.2 N-acetyl cysteine 
 
N-acetyl cysteine (NAC; Sigma) was used as a representative ROS scavenger. It was 
selected because it does not absorb UVR at wavelengths less than 280 nm (Figure 2.2). 
Following experiments utilising a range of NAC concentrations from 2-20 mM, 
concentrations of 10 and 20 mM were determined to provide significant protection 
against UVA-induced ROS (measured by the H2DCFDA assay). Stock solutions of NAC 
were diluted in PBS. Cells were pretreated with NAC 4 h prior to UVA (time was based 
on published literature). Media containing NAC were removed prior to irradiation and 










2.4.3 Stiefel compounds 
 
Stiefel laboratories supplied us with three compounds to be tested for antioxidant 
properties against UVR-induced oxidative stress. The compounds where screened by 
Stiefel as weak ligands of a skin receptor the company was interested in. These included 
a pharmaceutical excipient called farnesol (MW: 222.37), a guggulsterone plant extract 
composed of plant polyphenols (MW: 312.45), and a common wax emulsifier, 
lanosterol (MW: 426.71). The absorption spectra of these compounds are presented in 
figures 2.3, 2.4 and 2.5, respectively. 
Following investigations utilising various concentrations (in the range suggested by 
Stiefel laboratories), concentrations between 5 and 80 μM were chosen (please see 
Results section for further details). Cells were incubated routinely with the compounds 






























The main UVR source was a UVASPOT (400/T, Dr K Hönle UVTechnologie, Munich, 
Germany), the spectrum of which is shown in Figure 2.6 and described in Table 2.7. 
The erythemal effective energy (EEE) was calculated using the erythemal action 
spectrum of the International Commission on Illumination (CIE) (Webb et al., 2011). 
Irradiance was routinely determined with an International Light IL 442A radiometer 
(Newbury Port, MA, USA) with a UVA detector calibrated against the measurements 
made with a double-monochromator spectroradiometer (Bentham Instruments, Reading, 
UK), which was calibrated against a UK national standard. 
 
Cells were routinely irradiated in monolayers. Irradiation was always carried out at the 
same distance from the lamp (17 cm from the source), in cold PBS, with the lid always 
in place, to avoid contamination. The clear plastic lid was also placed on top of the 
detector when measuring the irradiance of the source. As the UVA source produced high 
levels of heat, a cooling platform set at a temperature of 6C was used, to keep the 
temperature at ~27C. Controls (unirradiated samples), and samples with shorter 
irradiation times, were maintained in PBS at the same temperature for the same time as 
the longest exposure to ensure that any differences observed occurred because of UVR 
dose differences, rather than prolonged time in PBS. Cells were always kept on ice, 




Figure 2.6:   Emission spectrum of the UVASPOT 
Spectrum was determined by a Bentham DM150 double monochromator 
spectroradiometer (Bentham Instruments, Reading, U.K.) through the plastic 
lid, at a distance of 39 cm. 
 
 
Following pilot investigations using various UVA doses from 1 to 40 J/cm2, and keeping 
in mind the physiological relevance of our irradiations, doses ranging from 5 to 20 
J/cm2 were selected as the standard protocol doses for the experiments. These doses 








UVR Region Wavelength (nm) 
% of total 
irradiance 
% EEE 
UVA 321-400 99.8 87.5 
UVAI 340-400 97.5 78.4 
UVAII 321-340 2.3 9.1 
UVB (CIE)* 281-315 0.1 10.4 
UVB 281-320 0.2 12.7 
UVC 200-280 0.0 0 
Total UVR 200-400 100 100 
 
Table 2.7: Spectroradiometric distribution of emission spectrum of the UVASPOT 
See Figure 2.6; Spectra were measured through the plastic lid of a 6-well plate used in 
the experiments. Respective erythemally effective energies (EEE) were obtained by 
multiplying with the CIE action spectrum for erythema (Webb et al., 2011).  This shows 
that the majority of the EEE was in the UVAI region. *official CIE definition of UVB, 




At an early stage of my project, UVB was used for some studies, to establish technique 
development, as well as UVB-induced DNA damage. Irradiations were conducted with 
an FS20 Westinghouse SunLamp (Westinghouse, Pittsburgh, PA), emitting mainly in 
the UVB range, with peak emission at 313 nm. The spectrum of the FS0 lamp is shown 
in Figure 2.7 and described in Table 2.8.  Irradiance was routinely determined with an 
International Light IL 442A radiometer, fitted with a UVB detector (SEE1240; 
Newbury Port, MA, USA), calibrated against the measurements made in the past with a 
double-monochromator Bentham spectroradiometer. Irradiations were always carried 
out in the same distance from the lamp (8 cm from the source). Cells in a 6-well plate 
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were washed twice with PBS and then irradiated in 1 ml of PBS (with Ca2+ and Mg2+) at 




Figure 2.7:      Emission spectrum of the FS20 Westinghouse SunLamp 
 
UVR Region Wavelength (nm) % of total irradiance % EEE 
UVA 321-400 45.3 0.7 
UVAII only 321-340 29.9 0.6 
UVB 281-320 54.8 99.4 
UVC 200-280 0.0 0.0 
Total UVR 200-400 100.0 100.0 
 
Table 2.8:  Spectroradiometric distribution of emission spectrum of the FS20 Westinghouse 
SunLamp 
Spectrum was determined by a Bentham DM150 double monochromator 





An XX-15s UV Bench Lamp (UVP) was used to generate UVC (254nm). Irradiation of 
cells was performed at a distance of 25 cm from the lamp, in PBS, without the lid. 
Exposure was based on time (10 and 20 s), and determined empirically because reliable 








































2.6 Cell viability/survival assays 
 
2.6.1 MTT-time course assay 
 
This assay measures the metabolism of 3-(4,5-dimethyl-thiazol-2-yl)-2,5-diphenyl 
tetrazolium bromide (MTT), a yellow tetrazolium salt, that is reduced by the 
mitochondria of metabolically active cells to form a blue formazan dye precipitate, 
which can be extracted using organic solvent (Mosmann, 1983).  
 
Seeding was at 104 cells/well into flat-bottomed 96-well plates and cells were allowed 
to recover for 24h at 37C in a humidified incubator, 5% CO2. Media was removed 
carefully and cells were washed twice with cold PBS (+Ca2+, Mg2+). Cells were then 
irradiated in 100 l of PBS, with the lid on. Control wells were covered with aluminium 
foil. Eight replicate wells were used for each UVA dose. After radiation, PBS was 
removed and replaced with normal fibroblast medium (200 l). After a 19h incubation 
period, cell viability was assessed. Aliquots (20 l) of MTT solution (10 mg/ml PBS) 
were added to each well and the plates were incubated for 4h at 37C followed by 
removal of the medium and addition of 100 μl of lysis solution (0.04 M HCl in absolute 
isopropanol) to each well. Plates were covered with foil and left on a plate shaker for 
approximately 10 min. The plates were subsequently read on a plate reader at 550 nm. 
The average absorbance reading was taken from each time point of each plate. Cell 








2.6.2 Trypan blue exclusion assay 
 
Immediately after UVR or treatment with various compounds, cell viability was 
determined using the trypan blue exclusion assay to ensure that no significant 
cytotoxicity was induced. Trypan blue (Sigma, UK) solution was added to aliquots of 
cell suspensions to a final concentration of 0.04% to estimate the number of viable cells. 
Viable (unstained) and non-viable (stained) cells were counted in a hemacytometer 
under an inverted microscope (Olympus, Tokyo, Japan); the percentage of viable cells 
was calculated for each condition tested. 
 
 
2.7 Reactive oxygen species production 
 
 
Detection of total intracellular ROS generation was performed using 5-(and-6)-carboxy-
2′,7′-dichlorodihydrofluorescein diacetate (carboxy-H2DCFDA). Carboxy-H2-DCFDA 
(Invitrogen, Paisley UK) was preferred as it is thought to have better retention in the 
cell due to a negative charge at physiological pH (Peter, 2007). 
 
Cells were cultured in 6-well plates to a confluence of approximately 80 %. Medium 
was removed and cells were rinsed (×2) with PBS. Cells were irradiated after the 
addition of 1 ml PBS containing 9 mM Ca2+ and 4.9 mM Mg2+ (Gibco, UK) in each 
well. Control cells remained in the dark at approximately the same temperature as the 
irradiated samples (less than ~30ºC).  After UVR exposure, 2 ml of 5 μM H2-DCFDA, 
diluted in PBS (containing 1 g/L glucose; Gibco) were added to each well. Only PBS 
was added in control wells. Cells were incubated for 20 min in the dark at 37C in a 
humidified incubator with 95% air/5% CO2. Plates were subsequently washed twice 
with PBS to completely remove any dye that had not been internalized by the cells. 
 72
Post-UVR loading of H2DCFDA in PBS has been reported to be the optimal protocol 
for this technique in order to avoid an exaggerated response of the dye to UVA (Boulton 
et al., 2011). 
 
After treatment, cells were trypsinized, centrifuged at 400 × g for 4 min at 4°C and 
resuspended in 0.5 ml of PBS + 0.1% (w/v) bovine serum albumin (BSA). Samples 
were then transferred to FACS tubes and analysed with a Becton Dickinson FACSAria 
II. The viable proportion of the cell population was quantified by the addition of 2.5 





























2.8 Single-cell gel electrophoresis (comet assay) 
 
DNA damage was assessed using the alkaline comet assay (pH~13) with specific 
modifications based on the cell type and the photolesion investigated (Cooke et al., 
2008a). The alkaline version of the comet assay was developed by N.P. Singh and 
colleagues in 1988 (Singh et al., 1988), to measure low levels of strand breaks with high 
sensitivity. The pH in which the unwinding of the DNA and electrophoresis takes place 
is extremely important, as it changes what lesions the assay detects. The neutral comet 
assay (pH 7-8) facilitates the detection of double strand breaks and cross links; At pH 
between 12.1-12.4, the detects single and double strand breaks, incomplete excision 
repair sites and cross links; At pH>12.6, the assay detects alkali labile sites (ALS) in 
addition to all types of lesions mentioned above (Miyamae et al., 1997). 
 
This assay is shown schematically in Figure 2.8. Routinely, ordinary, alcohol-cleaned 
clear glass microscope slides were pre-coated with agarose, by dipping in a staining jar 
containing melted 1% standard agarose in H2O. The backs of the slides were wiped 
clean, and they were left to dry. Slides were then stored at room temperature for future 
use. 
 
Cells were counted before UVR exposure and distributed in the wells of a 9-well (~103 
cells per well). After irradiation, cells were trypsinised and harvested into PBS, and 
subsequently transferred into Eppendorf tubes. Cells were then centrifuged at 400 × g 
for 4 min, at 4°C. Supernatants were discarded and pellets were kept on ice. Cells were 
mixed with 200 μl of low-melting point agarose (LMA) and 75 μl of the gel was quickly 
poured on agarose pre-coated slides. Coverslips were placed over the gels, and slides 
were kept in a tray on ice for 10 min to allow the agarose to set. Coverslips were gently 
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removed and slides were placed in a tank filled with lysis buffer (2.5 M NaCl, 100 mM 
EDTA, 10 mM acid Tris, 1% sodium sarcosinate, pH 10, 1% of Triton 100, and 10% 
DMSO) for 16h at 4°C, in the dark. 
 
After carefully removing lysis buffer, slides were washed with ice-cold ddH2O for 10 
min (covered to prevent any DNA damage due to light). Slides were immersed in 2 
changes of enzyme reaction buffer (9.5 g Hepes, 7.4 g KCl, 186 mg EDTA, 200 mg 
BSA, pH 8, diluted in ddH20), for 5 min each, at room temperature.  
 
The detection of specific photolesions requires the incorporation of an extra step; after 
the lysis of agarose-embedded cells, DNA can be digested with lesion-specific 
endonucleases (DNA repair enzymes of bacterial/phage origin) that recognise the 
lesions and convert them to strand breaks. Thus, range, specificity and sensitivity of the 
assay are significantly increased. 
 
2.8.1 8-oxoGua detection 
 
Oxidatively induced DNA damage was measured using the human 8-oxoguanine DNA 
glycosylase 1 (hOGG1)-modified comet assay. Gels were incubated with hOGG1 [3.2 
U/ml (New England Biolabs, UK) - diluted 1:100 in enzyme reaction buffer], or enzyme 
reaction buffer alone.  
 
2.8.2 CPD detection 
 
Cyclobutane pyrimidine dimers (CPD) were assessed using the T4 endonuclease V 
(T4endoV)-modified comet assay. Gels were incubated with T4endoV [0.1 U/ml (New 
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England Biolabs, UK) - diluted 1:500 in enzyme reaction buffer), or enzyme reaction 
buffer alone.  
 
Coverslips were placed on top of the gels to ensure equal distribution of the enzymes, 
and slides were incubated at 37°C in a humid atmosphere for 45 min.  
 
2.8.3 DNA unwinding and electrophoresis 
 
Slides were subsequently transferred into ice-cold electrophoresis buffer (NaOH 10 M, 
EDTA 200 mM, pH 13 in ddH2O) and incubated for 20 min in the dark. Electrophoresis 
was performed for 20 min at 25 V, 300 mA. Finally, slides were gently rinsed with 
neutralization solution (0.4 M TrisMABase, Sigma, pH 7.5) for 20 min and then washed 
with ddH20 for 10 minutes. Slides were allowed to dry at room temperature overnight. 
DNA was stained using 1 ml of propidium iodide (PI) solution at 2.5 μg/ml in PBS per 
slide, for 20 min. Slides were then washed with dd for 20 minutes. After drying in the 
oven (2-3h at 37°C), slides were ready for image analysis. Slides were examined at a 
magnification of 40×, using a Zeiss Axiophot epifluorescence microscope (Carl Zeiss, 
Germany) equipped with a green excitation filter. Pictures covering the whole area of 
the slides were taken with a Nikon camera linked to the microscope. Routinely, 50 
randomly selected cells per slide and 3 slides per experimental condition were analysed 
(n=150) with the comet scoring software Comet Score (TriTek Corp., Summerduck, 
VA). The tail intensity, defined as the percentage of DNA migrated from the head into 








































Figure 2.8: Schematic representation of the basic steps of the comet assay 
(I) Cells are embedded in a thin agarose gel. All cellular proteins are removed by lysis. 
Following lysis, certain DNA repair enzymes may be employed for the specific 
detection of various types of DNA damage. DNA is then allowed to unwind under 
alkaline conditions. DNA undergoes electrophoresis, allowing the broken DNA 
fragments/damaged DNA to migrate away from the nucleus. After PI staining, the gel is 
“read” for amount of fluorescence in head and tail. Image was adapted from the book 
DNA repair protocol (Günter Speit and Andreas Hartmann, 2005). (II) Comets stained 
with PI; (a) Control: undamaged DNA remains trapped in nucleus; (b) Damaged DNA 




Comet Comet tail 
Overall Comet length 
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2.9 A mechanistic approach to study UVA-induced DNA damage 
 
In order to have a better understanding of the UVA-induced photolesions studied above, 
we needed to obtain some mechanistic information. In order to distinguish between 
direct or indirect DNA damage, certain inhibitors of ROS-producing enzymes were 
employed. The aim of this approach was to target specific pathways of interest, to gain 
an insight on the role of free radicals in DNA damage.  
 
The compounds used were the following: 
 
(a) Rotenone:  it inhibits the mitochondrial respiratory chain complex I. Since the 
mitochondrial respiratory chain is one of the most important sites of ROS 
production under physiological conditions, inhibiting this pathway would help us 
test if ROS are involved in the formation of CPD. Rotenone was used at a 
concentration of 100 μM in DMEM for 30 min treatment prior to UVR. 
 
(b) Diphenyleneiodonium (DPI): DPI reduces superoxide anion production and ROS 
generation by inhibition of NADPH oxidase and other flavine-containing enzymes. 
Several groups have highlighted the importance of NADPH oxidase in UVA-
induced ROS; therefore, inhibiting this pathway can be crucial in understanding 
which radicals are involved in specific DNA damage. DPI was used at a 








2.10 Gene expression studies 
 
2.10.1 RNA isolation 
 
 
Total RNA for real-time RT-PCR was isolated using the Absolutely RNA Microprep kit 
(Agilent Technologies) according to the manufacturer’s protocol. 0.7 μl of β-
mercaptoethanol (β-ME) was added to 100 μl of lysis buffer for each sample of up to 5 
× 105 cells. A fresh mixture of lysis buffer and β-ME was prepared before each 
experiment. 100 μl of the lysis buffer–β-ME mixture was added to each cell sample. All 
tubes were mixed thoroughly (by vortexing and pipetting) to ensure samples were 
homogenized.  An equal volume (usually 100 μl) of 70% ethanol was added to each cell 
lysate and mixed thoroughly by vortexing for 5 sec. 
 
The mixtures were then transferred to RNA-binding spin cups seated in 2 ml collection 
tubes. Samples were mixed in a microcentrifuge for 1 min at maximum speed. Filtrates 
were discarded, while spin cups were retained. Spin cups were attached to new tubes 
and the matrixes were washed with low-salt buffer (600 μl). Samples were mixed by 
centrifugation for 1 min at maximum speed; the spin cup was retained and the filtrate 
was discarded. Spin cups were placed in new collection tubes and centrifuged for 2 min 
at maximum speed to dry the matrixes. DNase solution was added directly onto the 
matrix inside the spin cup of each sample, to remove DNases.  Samples were then 
placed in a 37°C incubator for 15 min. After the incubation 500 μl of high-salt wash 
buffer were added to each spin cup, and samples were mixed in a microcentrifuge at 
maximum speed for 1 min. Filtrates were discarded and the spin cups were returned to 
the collection tubes. Following a wash with 600 μl of low-salt buffer, tubes were 
centrifuged at maximum speed for 1 min. Filtrates were discarded and spin cups were 
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washed with 300 μl of low-salt wash buffer. Samples were then centrifuged at 
maximum speed for 2 min to dry the matrixes. Spin cups were finally transferred to 1.5 
ml collection tubes and 30 μl of Elution Buffer was added directly onto each matrix 
inside the spin cup. Samples were incubated at room temperature for 2 min and then 
centrifuged for 1 min. The RNA yield was determined by quantifying the samples on a 
Nanodrop ND1000 UV-vis Spectrophotometer (Labtech).  RNA samples were stored at 
–20°C for up to one month or at –80°C for long-term storage, until PCR. 
 
2.10.2 cDNA synthesis 
 
cDNA synthesis was carried out on 500 ng of total RNA using the QuantiTect reverse 
transcription kit (Qiagen) according to the manufacturer’s instructions. 
 
2.10.3 Real Time RT-PCR 
 
Gene expression was assessed by singleplex real-time quantitative RT-PCR using 
Taqman Gene Expression Assays according to the manufacturer’s instructions. cDNA 
samples were diluted with distilled water to a final concentration of 500 ng/μl per 
sample. Probes labeled with 6-carboxyfluorescein (FAM) used for real-time RT-PCR 
were purchased as “Assay-on-Demand” from Applied Biosystems. The target genes 
were matrix metalloprotease 12 (MMP12) [Hs00899668_m1] and heme oxygenase 1 
(HO1) [Hs00157965_ml]; HO1 is a well-studied gene, known to be induced by UVA 
irradiation (Tyrrell, 2004). MMP12 was chosen as it was strongly upregulated in a pilot 
human study, following microarray analysis. Human β2-Macroglobulin (B2M) 
[Hs99999907_m1] was used as a housekeeping gene as well as Human Glyceraldehyde 
3-phosphate dehydrogenase (GAPDH), which was labeled with 4,7,2′-trichloro-7′-
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phenyl-6-carboxyfluorescein (VIC). Reactions were performed using 10 μl of 1X 
TaqMan Universal PCR master mix (Applied Biosystems, Foster City, CA), 1 μl of the 
appropriate probe, and 2 μl cDNA (500 ng/μl), in a total volume of 20 μl. All PCR 
reactions were carried out in triplicates in 96 well plates covered by optical adhesive 
lids. Samples were amplified in an Applied Biosystems 7900HT Sequence Detection 
System, under the following conditions: 15 min 95°C; (15 s 95°C, 1 min 60°C) x 40. 
After amplification, relative expression levels for MMP12 and HO1 were analyzed 
using the ΔΔCt method as described in the following section. 
 
 
2.10.4 Analysis of real-time PCR data 
 
The expression of transcripts of interest was normalized to that of the β2-Macroglobulin 
and GAPDH housekeeping genes. Data analysis was performed using the Cycles 
threshold (Ct) method, which does not require the use of a standard curve (Livak and 
Schmittgen 2001; Lopez-Albaitero, Mailliard et al. 2009). The Ct value was 
calculated using the formula: ΔΔCt = (CtGOI – CtHK), where CtGOI and CtHK are the 
averaged Ct values for the gene of interest and the housekeeping gene. Data were 
expressed as mRNA expression fold changes, relative to a calibrator sample. Assuming 
a doubling of material during each PCR cycle, this relative quantification (RQ) was 










2.11 Total glutathione (GSH) measurement 
 
 
Intracellular concentrations of reduced glutathione (GSH) were measured using the 
GSH/GSSG kit (Calbiochem, cat. no. 371757). Reduced glutathione (GSH), a tripeptide 
(γ-glutamylcysteinylglycine) with a free thiol group, is a major antioxidant in human 
tissues that provides reducing equivalents for the glutathione peroxidase (GPx) 
catalyzed reduction of hydrogen peroxide and lipid hydroperoxides to water and the 
respective alcohol. During this process GSH becomes oxidized glutathione (GSSG). 
The GSSG is then recycled into GSH by gutathione reductase (GR) and β- nicotinamide 
adenine dinucleotide phosphate (NADPH). When mammalian cells are exposed to 
increased oxidative stress, the ratio of GSH/GSSG will decrease as a consequence of 
GSSG accumulation. Measurement of the GSSG level or determination of the 
GSH/GSSG ratio is a useful indicator of oxidative stress and can be used to monitor the 
effectiveness of antioxidant intervention strategies. 
 
The technique employs a chromogen known as Ellman’s reagent (5,5'-dithiobis-2-
nitrobenzoic acid or DTNB), which reacts with GSH to form a spectrophotometrically 
detectable product at 412 nm. GSSG can be determined by the reduction of GSSG to 
GSH, which is then determined by the reaction with the chromogen. The change in 
color development during the reaction, and the reaction rate is proportional to the GSH 
and GSSG concentrations.  
 
Cell pellets were homogenized in 50 μl of cold metaphosphoric acid (5% w/v) and 
resuspended in a total volume of 500 μl. The homogenate was centrifuged for 10 min 
(3,000 x g) at 4˚ C and 100 μl of the resulting supernatant was analysed by 
spectrophotometry using a UV-Vis Spectrophotometer. 
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2.12 Immuno-Slot-Blot (ISB) for the detection of UVA-induced CPD 
 
UVB-irradiated calf-thymus DNA (CT-DNA) was used to establish the technique 
worked. 
 
DNA from cells was isolated using the DNeasy Blood & Tissue Kit (Qiagen), according to 
the manufacturer’s instructions.  
 
3.5 μg of each DNA sample were sonicated in a water bath for 20 min to obtain 
approximately 100 base pair long fragments. DNA was then boiled for 5 min to produce 
single-stranded DNA, prior to being placed on ice for 10 min, and then mixed with an 
equal volume of 2 M ammonium acetate. Single-stranded DNA was then immobilised 
on nitrocellulose (NC) filters using a Minifold II, 72-well Slot-Blot microfiltration 
apparatus (Schleicher and Schuell, Keene, NH, USA). Prior to use, the NC filters were 
presoaked in 1 M ammoniun acetate. After loading the DNA, the slots were rinsed with 
200 μL of 1 M ammonium acetate. The NC filters were then removed from the filter 
support and baked at 80°C for 90 min.  
 
The filters were then immersed in 100 mL of PBS-Tween (PBS with 0.1% Triton X-100 
were added) plus 5% non-fat milk powder for 1h at room temperature. After extensive 
washing in PBS-Tween with several buffer changes, the NC filters were incubated with 
anti T<>T monoclonal antibody (Anti-Thymine Dimer mAb, clone KTM53; Kamiya 
Biomedical Company, Seattle, WA USA) diluted 1 in 4,000 in PBS-Tween plus 0.5% 
milk powder, for 1h at room temperature followed by two further 5 min washes with 
PBS-Tween. The filters were then incubated with the secondary antibody (goat anti 
mouse immunoglobulin horse radish peroxidase conjugated; Dako A/S, Glostrup, 
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Denmark). The secondary antibody was diluted 1 in 4,000 in PBS-Tween plus 0.5% 
milk powder. The filters were allowed to rock in plastic boxes for 2 h, at room 
temperature. The filters were then washed with PBS-Tween by gentle rocking in a tray 
for 15 min followed by two further 5 min washes. Care was taken not to let the filters 
dry out. Enzymatic activity was visualised by bathing the NC membrane with Super 
Signal West Dura Extended Duration Substrate for 5 min (Pierce, IL, USA). The 
substrate working solution was prepared immediately before use by mixing equal 
volumes of the ultra luminol/enhancer solution with the ultra stable peroxide solution. 




Quantification of T<>T in each DNA sample was obtained by scanning the blots on a 
ChemiGenius2 image acquisition system (Syngene, Cambridge, UK) and obtaining a 
chemiluminescencent image of the nitrocellulose filter. The frame width fitting the slot 
areas was drawn and stored, and chemiluminescence intensities (relative units) per slot 
area were quantified using the Gene tools software (Syngene, Cambridge, UK). 
 
2.13 Statistical analysis 
 
All experiments were conducted in triplicates and values are presented as mean ± 
standard error of the mean (SEM). Statistical analysis was conducted with GraphPad 
Prism version 4.0 (GraphPad software, San Diego, CA). Two-way ANOVA with 
Bonferroni multiple comparison post-test was chosen for the comet assay and one-way 
ANOVA with Bonferroni post-test was used for cell viability assay analyses. Student’s 
unpaired t-test was chosen for all other analyses. Significance limits were set at *p< 



















































The chapter is divided into six studies, each of which is further subdivided in several 
sections, starting with the development of the comet technique and the optimisation 
experiments that established the parameters selected in the main experiments.  
 
Study 1: UVB-induced DNA damage for technique development and optimisation 
of concentrations of DNA restriction enzymes and vitamin E. 
 
Study 2: Time-course/repair kinetics experiments to establish DNA repair time-
points for specific types of UVA-induced DNA damage.  
 
Study 3: Pre- and post-UVR effect of vitamin E against UVA-induced DNA 
damage and oxidative stress. 
 
Study 4: Assessment of NAC in the protection against UVA-induced DNA 
damage. 
 
Study 5: Real time PCR for detection of HO-1 and MMP-12 induction by UVA. 
 
Study 6: ROS pathways inhibitors study. 
 




3.1 Study of UVB-induced DNA damage for technique development 
 
Due to some complications with the UVA source early in my PhD, a UVB source was 
employed to develop the comet assay, especially for CPD measurements, as UVB is 
known to readily induce CPD. Enzyme concentrations used for the UVB experiments 
were based on the experience of my second supervisor’s laboratory, Dr Marcus Cooke, 
and on protocols supplied by Dr Tiago Duarte (Leicester Univesity, Department of 
Cancer Studies and Molecular Medicine and Genetics). These experiments helped 
establish the routine use of the technique in the laboratory. 
 
3.1.1 UVB-induced DNA damage on HaCaT keratinocytes 
 
The effect of increasing doses of UVB irradiation on cell viability is shown on Table 
3.1. Representative images of comets produced by UVB irradiation are presented in 
Figure 3.1. No comet tails were observed on cells exposed to 50 mJ/cm2, without any 
enzyme (ALS/SB), or with hOGG1. Small comet tails were formed with 100 mJ/cm2 in 
these two groups (Figures 3.1a and 3.1b). HaCat cells treated with T4endoV exhibited 
significantly increased comet tails compared to the rest (Figure 3.1c).  
UVB dose (mJ/cm2) Viable cells (%) 
0 92.9 ± 2.6 
50 84.2 ± 4.1 
100 79.3 ± 3.9 
200 73.8 ± 4.5 
300 66.5 ± 5.2 
 
Table 3.1: HaCaT cell viability following UVB irradiation  
Cell viability was assessed immediately after UVB irradiation by the MTT assay. Data 
represent the mean of three independent experiments ± SEM. One-way ANOVA with 
Bonferroni correction showed significant differences between dose increments (p<0.001 
in all cases). 
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A dose-dependent increase in the formation of CPD, 8-oxoGua and ALS/SB was 
observed following UVB irradiation of HaCat keratinocytes (Figure 3.2a). CPD levels 
were much greater than 8-oxoGua levels as expected, since UVB is directly absorbed by 
DNA. Figure 3.2b shows the frank CPD and 8-oxoGua levels (background correction 












Figure 3.2a:    Effect of UVB irradiation on the formation of 8-oxoGua, CPD and ALS/SB 
detected by the hOGG1- and the T4endoV-modified comet assay 
The mean percentage of tail DNA in HaCaT cells exposed to UVA doses of 50 and 100 
mJ/cm2. Results are the mean SEM of three independent experiments (50 comets 
scored per experiment); p<0.0001 in all cases when comparing irradiated samples to 
their corresponding non-irradiated samples; p<0.05 in all cases when comparing “No 










Figure 3.2b:  Effect of UVB irradiation on the formation of 8-oxoGua and CPD formation as 
detected by the hOGG1- and the T4endoV-modified comet assay (background 
corrected) 
Mean percentage of tail DNA HaCaT cells exposed to UVB doses of 50 and 100 
mJ/cm2.  Background correction was performed using no enzyme values for each group. 










3.2 Optimisation of hOGG1, T4endoV and vitamin E concentrations for 
the comet assay 
 
In order to determine the ideal concentrations of the DNA repair enzymes used in the 
UVA studies, various concentrations of hOGG1 and T4endoV were tested, based on the 
protocol provided by Dr Tiago Duarte. Based on that, optimal concentrations for the 
hOGG1-modified comet assay ranged between 3-4 U/mL, while for the T4endoV-
modified comet assay ranged between 0.05-0.15 U/mL. Pilot studies confirmed these 
ranges and the final concentrations chosen for all the experiments were 3.2 U/mL for 
hOGG1 (Figure 3.3), and 0.1 U/mL for T4endoV (Figure 3.4), which is at the top of the 
dose responses, after which there is a plateau.  
 
Vitamin E was originally chosen in this study as a potent antioxidant and an ideal 
compound for technique development and assessment. However, as the initial 
experiments produced some interesting data, vitamin E was further investigated. 









Figure 3.3:  Optimisation of hOGG1 concentration by the comet assay 
HaCaT keratinocytes were irradiated with 5 J/cm2 UVA and were subsequently 
incubated with different concentrations of enzyme for 45 min. Results are the mean 








Figure 3.4:   Optimisation of T4endoV concentration by the comet assay 
HaCaT keratinocytes were irradiated with 5 J/cm2 UVA and were subsequently incubated 










Figure 3.5: Optimisation of vitamin E concentration (without the use of any DNA repair 
enzymes) 
HaCaT keratinocytes were incubated with different concentrations of vitamin E (diluted 
in EtOH) for 24 h, and then washed thoroughly with PBS; they were subsequently 



















3.2.1 Cell viability 
 
UVA exposure doses were chosen based on published literature, physiological 
relevance and cell viability assays (Table 3.2). 
 
UVA dose (J/cm2) Viable cells (%) TB Viable cells (%) MTT 
0 90.3 ± 4.2 89.9 ± 3.8 
2.5 89.7 ± 5.1 88.7 ± 2.1 
5 88.6 ± 3.3 88.0 ± 3.9 
10 85.3 ± 4.6 84.4 ± 3.4 
20 82.3 ± 2.9 81.2 ± 4.3 
40 79.7 ± 5.0 80.1 ± 4.2 
80 73.2 ± 4.6 71.1 ± 5.3 
 
Table 3.2:  HaCaT cell viability following UVA irradiation 
Cell viability was assessed immediately after UVA irradiation by the trypan blue (TB) 
exclusion and the MTT assays. Data represent the mean of three independent 
experiments ± SEM. One-way ANOVA with Bonferroni correction showed significant 
differences between dose increments (p<0.05 in all cases). 
 
Based on Table 3.2, the dose range of between 5-20 J/cm2 was chosen, but in some 
cases a dose of 40 J/cm2 was given. The average time to give a dose of 20 J/cm2 was 11 
min. Furthermore, cell viability was not significantly altered by UVA exposure or 
vitamin E supplementation for 24 h (Table 3.3), as demonstrated by both trypan blue 
exclusion assay and the MTT assay. 
 
Treatment Viable cells (%) TB Viable cells (%) MTT 
Control* 87.3 ± 3.2 88.7 ± 2.5 
20 J/cm2 UVA* 81.8 ± 4.3 80.1 ± 3.6 
Vitamin E 88.6 ± 2.5 89.2 ± 2.0 
20 J/cm2 UVA  + Vitamin E 85.9 ± 1.6 86.5 ± 2.5 
 
Table 3.3:  HaCaT cell viability following UVA ± vit E 
Cell viability was assessed by the trypan blue (TB) exclusion and the MTT assays. Data 
represent the mean of three independent experiments ± SEM. One-way ANOVA with 
Bonferroni correction showed significant differences between all groups (p<0.05). 
*Cells incubated with EtOH for 24 h. 
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3.3 Time-course experiments to establish DNA repair time-points for 
specific types of UVA-induced DNA damage 
 
 
The comet assay was employed to measure the repair kinetics of 8-oxoGua, CPD and 
non-enzyme specific lesions (ALS/SB) after 5 J/cm2 UVA, over a period of 10 h. 
Following UVR, samples were left to repair in their conditioned media, at 37C in a 
humidified incubator with 95% air/5% CO2. 
 
Both photolesions increased over a period of 30 min; however, formation of 8-oxoGua 
continued to increase up to1 h after UVR, while CPD levels started to decline after 30 
min. 8-oxoGua reached control levels at 10 h whereas the level of CPDs decreased at a 
slower rate (Figure 3.6). Slide incubation in the absence of hOGG1 and T4endoV 
measured alkali labile sites (ALS) and frank strand breaks (SB). Repair kinetics for 












Figure 3.6:  Induction and repair of UVA-induced 8-oxoGua and CPDs, over 10 h 
HaCaT keratinocytes were irradiated with 5 J/cm2 UVA and were left to repair for 


















It should be noted in Figure 3.6, that the ALS/SB values measured by the assay without 
any enzymes, have not been subtracted from the values obtained by the hOGG1 and the 
T4endoV comet assay. This approach was taken in order to follow the formation of ALS 
and SB due to UVA irradiation. The same principle was followed in the sections 
presenting comet data below. In most cases, the difference between enzyme-treated 
(specific DNA damage) and the non-treated (ALS/SB) was big enough to obtain a clear 
indication of the effects of the compounds used in each study. However, in order to have 
a more accurate observation of each compound tested by the comet assay, graphs 
presenting the frank 8-oxoGua and CPD values were also plotted, in which the 
corresponding background values (ALS/SB) were subtracted from the hOGG1 and 
T4endoV-obtained values.  
 
Figures showing all types of damage were produced by plotting the mean of 150 comets 
(obtained from three different experiments) for each group studied (± enzyme and ± 
compound). For background-corrected graphs the mean from each non-enzyme treated 
group (n=3, 50 comets per experiment) was subtracted from the corresponding (same 










3.4 Pre- and post-UVR effect of vitamin E against UVA-induced DNA 
damage and oxidative stress 
 




ROS generation was quantified by carboxy-H2DCFDA staining, in which the outcome 
is measured as fluorescence. An increase in ROS was observed with increasing UVA 
doses (10, 20 and 40 J/cm2), as shown in Figure 3.7; cells pre-treated with vitamin E for 
24 h prior to UVR exhibited a lower fluorescence. Vitamin E offered significant 
protection at all UVA doses. This was highly significant at 40 J/cm2 with a 33% 
reduction of ROS compared to the control. Vitamin E did not alter the level of 









Figure 3.7:  Comparison of ROS production between control (EtOH) and pre-UVR treated (+ 
vit E) groups 
 
Fluorescence intensity of H2DCFDA was excited at 488 nm. Results are the mean of 
three independent experiments SEM. The UVR dose-responses were determined by 
linear regression analyses.  The R2 values for both test conditions were >0.97 and both 
slopes were very significantly different from zero (p<0.0001), which demonstrates a 
strong dose-response. The control slope was significantly steeper than the vitamin E-
treated slope (p<0.001), demonstrating a clear protection, which is more marked with 










A clear dose-dependent increase in both 8-oxoGua and CPD formation immediately 
after irradiation was demonstrated (Figures 3.8a and 3.8b). DNA damage in the absence 
of lesion-specific enzymes, representing ALS/SB levels, was also observed (Figure 
3.8a). This possibly includes apurinic/apyrimidinic sites and some forms of alkali-labile 
modified nucleobases, as well as single strand breaks (Cadet et al., 2000).  
 
HaCaT keratinocytes pretreated with vitamin E exhibited a decrease in 8-oxoGua levels 
at both UVA doses. The effect was greater at 5 J/cm2 (approximately 61% decrease; 
p<0.0001). A significant decrease in CPD levels was also observed, present at both UVA 
doses (52% and 33 % decrease at 5 and 10 J/cm2 respectively). DNA damage levels 
induced by UVR were statistically significant (p<0.0001) compared to the 
corresponding controls (unirradiated cells). 
 
Comet analysis in the absence of any enzyme treatment suggests that a large percentage 
of the damage was ALS/SB sites. Comparisons between enzyme-treated and non-treated 
samples, in the absence of vitamin E, were statistically significant (p<0.0001) in all 
cases. This demonstrates the presence of a high level of enzyme-specific damage i.e. 
damage to nucleobases. Vitamin E also offered significant (p<0.0001) protection 
against non-specific (ALS/SB) DNA damage. Figure 3.8b shows vitamin E’s effect on 
frank 8-oxoGua and CPD formation, following background correction (subtraction of 







Figure 3.8a:  Effect of pre-UVR incubation with vitamin E on 8-oxoGua, CPD and ALS/SB 
formation detected by the hOGG1- and the T4endoV-modified comet assay 
The mean percentage of tail DNA in HaCaT cells exposed to UVA doses of 5 and 10 
J/cm2. Results are the mean SEM of three independent experiments (50 comets scored 
per experiment); p<0.0001 in all cases when comparing irradiated samples to their 
corresponding non-irradiated samples; p<0.001 in all cases when comparing “No enz” 















Figure 3.8b:  Effect of pre-UVR incubation with vitamin E on 8-oxoGua and CPD formation as 
detected by the hOGG1- and the T4endoV-modified comet assay (background 
corrected) 
Mean percentage of tail DNA HaCaT cells exposed to UVA doses of 5 and 10 J/cm2.  
Background correction was performed using no enzyme values for each group. Results 
are the mean SEM of three independent experiments; **p<0.001, *p< 0.05 for 





3.4.2 Post-UVR treatment with vitamin E also offers significant protection 
against ROS formation and DNA damage 
 
 
As shown in the spectral distribution of the UVASPOT (see Materials and Methods, 
Table 2.7), the very small UVB content (0.1-0.2%, depending on definition) of the 
source used contributes 10.4-12.7% of the EEE. Given the similarity of the action 
spectra for erythema and CPD in human skin in vivo (Young et al., 1998), it may be 
assumed that UVB makes a comparable contribution to CPD formation. Figure 2.1 (see 
Materials and Methods) shows that vitamin E has some UVB absorption, which 
overlaps with the emission spectrum of the source. In order to examine a possible 
sunscreening effect of vitamin E, the experiments were repeated with post-UVR 
treatment with vitamin E. Various post-UVR incubation times were tested in pilot 
studies and an incubation of 2.5 h was selected as the shortest period with a significant 




A similar effect on ROS to that after pre-UVR treatment with vitamin E was observed 
(Figure 3.9). Cells treated with vitamin E for 2.5 h after UVR exposure, again exhibited 
lower fluorescence levels. However, mean fluorescence values were greater in general, 
compared to those found in the pre-UVR treatment experiment. As with pre-incubation, 







Figure 3.9:  Comparison of ROS production between control (EtOH) and post-UVR treated (+ 
vit E) groups 
Fluorescence intensity of H2DCFDA was excited at 488 nm. Results are the mean of 
three independent experiments SEM. The UVR dose-responses were determined by 
linear regression analyses.  The R2 values for both test conditions were >0.91 and both 
slopes were very significantly different from zero (P<0.0001), which demonstrates a 
strong dose-response. The control slope was significantly steeper than the vitamin E-
treated slope (p<0.05), demonstrating a clear protection, which is more marked with 







DNA photolesions   
 
Figures 3.10a and 3.10b demonstrate the effect of post-UVR treatment with vitamin E 
on DNA damage. Similarly to the pre-UVR treatment experiment, a clear dose-
dependent response in 8-oxoGua, CPD and ALS/SB formation was observed (Figure 
3.10a). DNA damage levels in general were lower in the post-UVA exposure vitamin E 
treatment experiment, compared to the pre-UVA exposure vitamin E treatment 
experiment results. Vitamin E treatment after UVR reduced levels of hOGG1-detected 
sites at both doses tested. The strongest effect of vitamin E (0.1 mM) was again 
observed at 5 J/cm2 at which 8-oxoGua and CPD levels exhibited a 67% and 65% 












Figure 3.10a: Effect of post-UVR incubation with vitamin E on 8-oxoGua, CPD and ALS/SB 
formation as detected by the hOGG1- and the T4endoV-modified comet assay 
Mean percentage of tail DNA HaCaT cells exposed to UVA doses of 5 and 10 J/cm2.   
Results are the mean SEM of three independent experiments; p<0.0001 in all cases 
when comparing irradiated samples to their corresponding non-irradiated samples; 















Figure 3.10b: Effect of post-UVR incubation with vitamin E on 8-oxoGua and CPD formation as 
detected by the hOGG1- and the T4endoV-modified comet assay (background 
corrected) 
Mean percentage of tail DNA HaCaT cells exposed to UVA doses of 5 and 10 J/cm2.  
Background correction was performed using no enzyme values for each group.Results 
are the mean SEM of three independent experiments; **p<0.001, *p< 0.05 for 








3.4.3 Vitamin E does not protect against UVC-induced formation of CPD but 
does protect against the formation of 8-oxoGua and ALS/SB 
 
Some experiments were also performed with UVC (254 nm) because it is a potent 
inducer of CPD. As expected, there was a very large difference (p<0.0001) between 
non-specific damage (ALS/SB) and that observed with T4endoV (Figure 3.11a). UVC 
also induced the formation of 8-oxoGua. Pre-incubation with vitamin E reduced non-
specific damage and 8-oxoGua levels, but had no effect on CPD formation. This was 









Figure 3.11a: Effect of pre-incubation with vitamin E on UVC-induced formation of CPD, 8-
oxoGua and ALS/SB.  Mean percentage of tail DNA HaCaT cells exposed to UVC 
for 10 sec 
Results are the mean SEM of three independent experiments; p<0.0001 in all cases 
when comparing irradiated samples to their corresponding non-irradiated samples; 








                  
 
 
Figure 3.11b:   Effect of pre-incubation with vitamin E on UVC-induced formation of CPD and 8-
oxoGua.  Mean percentage of tail DNA HaCaT cells exposed to UVC for 10 sec 
(background corrected) 
Background correction was performed using no enzyme values for each group. Results 
are the mean SEM of three independent experiments; *p<0.05 for selected 





3.4.4 Vitamin E treatment prior to UVA significantly protects against T<>T 
formation 
 
It was decided to validate the T4endoV comet data with a different assay to measure 
CPD. UVB irradiation (doses ranging from 0 to 1 J/cm2) was used for the induction of 
CPD in order to develop the immuno-slot blot technique (Figure 3.12). This shows a 
dose-response with a plateau starting at 0.5 J/cm2. 
 
Pre-UVA treatment with vitamin E reduced the formation of UVA-induced (20 J/cm2) 
T<>T by 37%, as observed from the immuno-slot blot (Figure 3.13). On the other hand, 
post-UVA treatment did not have a significant effect. It is worth noting that CPD levels 
were lower in the post-UVA treatment experiment, indicating DNA repair during the 
2.5 h incubation period with vitamin E (samples were kept at 37ºC during post-UVA 























Figure 3.12:  UVB-irradiated (0-1 J/cm2) CT-DNA was analyzed with the immuno-slot blot 
assay by using a T<>T-specific mAb 
See Materials and Methods section 2.12; Results are the mean SEM of three 
independent experiments, with each experiment run in triplicate. Image is representative 
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Figure 3.13:  Genomic DNA of UVA-irradiated (20 J/cm2) HaCaT keratinocytes was analyzed 
with immuno-slot blot assay by using a T<>T-specific mAb 
Results are the mean SEM of three independent experiments, with each experiment 









3.4.5 Vitamin E increases total GSH levels in HaCaT keratinocytes and protects 
against UVA-induced GSH depletion 
 
24h incubation with vit E increased total intracellular GSH levels by 2.3-fold (p=0.002) 
in HaCaT keratinocytes. Furthermore, vitamin E also protected against UVA-induced 
depletion, maintaining GSH levels in control levels (Figure 3.14). While UVA (20 
J/cm2) caused a 73% decrease of GSH levels in the untreated group, the decrease 
observed in the vitamin E-treated group was approximately 53%. This effect has been 
shown in the past (Masaki et al., 2002) and along with the results presented in this 
study, it is clearly demonstrated that vitamin E has numerous advantages in 













Figure 3.14:  Effect of UVA (±vit E) on total GSH levels in HaCaT keratinocytes 
HaCaT keratinocytes were supplemented with vit E for 24h prior to UVA irradiation. 





















3.5 Assessment of NAC in the protection against UVA-induced DNA 
damage 
 
N-acetylcysteine (NAC) is a thiol with antioxidant properties. It is a cell permeable 
GSH pro-drug. NAC protects against oxidatively induced DNA damage and UVR-
induced melanoma in mice (Cotter et al., 2007). Topical application of NAC reduces 
UVR-mediated depletion of GSH and H2O2 in human skin (Kang et al., 2003). 
Additionally, NAC has been found to reduce UVR-induced tumour formation in mice 
(D'Agostini et al., 2005). 
 
As shown in Figure 2.2 in Materials and Methods, NAC does not absorb in the UVR 
waveband (van den Broeke and van Henegouwen, 1995). Therefore, NAC was an ideal 
compound because it has no sunscreen properties, and any protective effects could only 
be attributed to its antioxidant properties. Incubation with NAC had no significant effect 
on cell viability, as shown in Table 3.4. 
 
NAC concentration (mM) Cell viability (%) 
  0* 91.9 ± 2.7 
2 90.8 ± 3.3 
5 90.5 ± 2.9 
10 92.3 ± 2.5 
20 91.1 ± 3.5 
 
Table 3.4:  HaCaT cell viability following incubation (4 h) with various concentrations of 
NAC 
Cell viability was assessed by the trypan blue exclusion assay. Data represent the mean 
of three independent experiments ± SEM. One-way ANOVA with Bonferroni correction 
shoed significant differences between NAC concentration increments (p<0.05 in all 
cases). *Cells incubated with PBS for 4h. 
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3.5.1 NAC protects against UVA-induced ROS and GSH depletion 
 
Treatment with 10 mM NAC for 4 h prior to irradiation significantly protected against 
UVA-induced ROS formation (Figure 3.15). The effect was stronger at 20 J/cm2, where 
a 30% reduction of ROS levels was observed in the NAC-treated group. 
 
Incubation with NAC also increased total intracellular GSH levels by 2.7-fold (p=0.007) 
in HaCaT keratinocytes. It also offered protection against UVA-induced depletion of 
total GSH, as observed in Figure 3.16. UVA (20 J/cm2) caused a 79% decrease of GSH 












Figure 3.15:  Comparison of ROS production between control and NAC-treated groups 
Fluorescence intensity of H2DCFDA was excited at 488 nm. Results are the mean of 
three independent experiments SEM. The UVR dose-responses were determined by 
linear regression analyses.  The R2 values for both test conditions were >0.96 and both 
slopes were very significantly different from zero (p<0.0001), which demonstrates a 
strong dose-response. The control slope was significantly steeper than the NAC-treated 

















Figure 3.16:  Effect of NAC on total GSH levels in HaCaT keratinocytes 
 HaCaT keratinocytes were supplemented with 20 mM NAC for 4h prior to UVA 

























Treatment of HaCaT keratinocytes with NAC (10 mM, 4 h prior to 5 J/cm2 of UVA) 
offered significant protection against the formation of 8-oxoGua. This effect was clear 
in Figure 3.17a (29% reduction). However, although a small decrease was observed in 
CPD levels in Figure 3.17a, background correction by the removal of the appropriate 
no-enzyme treatment values (measuring ALS/SB levels) showed that NAC had no effect 


















Figure 3.17a:  Effect of pre-UVR incubation with NAC on 8-oxoGua, CPD and ALS/SB 
formation as detected by the hOGG1- and T4endoV-modified comet assay 
The mean percentage of tail DNA in HaCaT cells exposed to UVA (5 J/cm2).  Results 
are the mean SEM of three independent experiments; p<0.0001 in all cases when 
comparing irradiated samples to their corresponding non-irradiated samples; p<0.0001 










Figure 3.17b:  Effect of pre-UVR incubation with NAC on 8-oxoGua and CPD levels 
(background corrected)  
The mean percentage of tail DNA in HaCaT cells exposed to UVA (5 J/cm2).  
Background correction was performed using no enzyme values for each group. Results 
are the mean SEM of three independent experiments; **p<0.001 for the selected 








3.6 Real time PCR for detection of HO-1 and MMP-12 induction by UVA 
 
All PCR experiments presented in this study were repeated using two different 
housekeeping genes, GAPDH and B2M. In all occasions results were very similar; 
Primarily, GAPDH was selected as the gene to which data were normalized, while some 
B2M data are also presented in this section to show data integrity. 
 
Induction of HO1 by UVA irradiation was measured by quantitative real-time Taqman 
PCR, using specific probes for HO1 and MMP12 mRNA. HO1 was selected as an 
established marker of oxidative stress (Vile et al., 1994), while MMP12 was selected 
because it was highly upregulated by UVA in an in vivo microarray pilot study 
conducted by our group. Time-course studies showed that the highest HO1 levels were 
reached 3 h following UVA irradiation (Figure 3.18), while MMP12 levels reached their 








Figure 3.18:  Time-course assay for HO1 induction following UVA irradiation (20 J/cm2) 
Transcript levels were quantified in HaCaT keratinocytes. Results are expressed as the 
mean SEM of the HO1/GAPDH ratio observed in three independent experiments, with 



















UVA-induced HO1 expression was similar in all cell lines used, with both 
housekeeping genes tested (Figures 3.19a and 3.19b). The effect of vitamin E pre-
treatment in HO1 induction was assessed in HaCaT keratinocytes and the immortalised 
fibroblast cell line MRC5V1. 
 
Treatment of HaCaT keratinocytes with vitamin E offered a significant protection 
(~28% decrease) against UVA-induced expression of HO1 (Figure 3.20). A similar, 












Figure 3.19a:  Real-time PCR analysis of HO1 expression in three different cell lines, 3 h after 
UVA irradiation 
Transcript levels were quantified using the GAPDH housekeeping gene as an 
endogenous control. The HO1/GAPDH ratio was set as a baseline value to which 














Figure 3.19b:  Real-time PCR analysis of HO1 expression in three different cell lines, 3 h after 
UVA irradiation 
Transcript levels were quantified using the B2M housekeeping gene as an endogenous 
control. The HO1/B2M ratio was set as a baseline value to which transcript levels were 










Figure 3.20:  Real-time PCR analysis HO1 expression in HaCaT keratinocytes (± vit E 
pretreatment) 3 h after UVA irradiation 
Transcript levels were quantified using the GAPDH housekeeping gene as an 
endogenous control. The HO1/GAPDH ratio was set as a baseline value to which 
transcript levels were normalized. Results are the mean of three independent 











Figure 3.21:  Real-time PCR analysis of HO1 expression in MRC5V1 fibroblasts (± vit E 
pretreatment), 3 h after UVA irradiation 
Transcript levels were quantified using the GAPDH housekeeping gene as an 
endogenous control. The HO1/GAPDH ratio was set as a baseline value to which 
transcript levels were normalized. Results are the mean of three independent 










Figure 3.22:  Time-course assay for MMP12 induction following UVA irradiation (20 J/cm2) 
Transcript levels were quantified in HaCaT keratinocytes. Results are expressed as the 
mean SEM of the MMP12/GAPDH ratio observed in three independent experiments, 



















UVA-induced MMP12 expression was similar in all cell lines used, with both 
housekeeping genes tested (Figures 3.23a and 3.23b). Vitamin E pre-treatment had no 
significant effect in UVA-induced MMP12 expression in HaCaT keratinocytes and 
MRC5V1 fibroblasts as seen in Figures 3.24 and 3.25, respectively (small reduction in 















Figure 3.23a:  Real-time PCR analysis of MMP12 expression in three different cell lines, 12 h 
after UVA irradiation (20J/cm2) 
Transcript levels were quantified using the GAPDH housekeeping gene as an 
endogenous control. The MMP12/GAPDH ratio was set as a baseline value to which 
transcript levels were normalized. Results are the mean of three independent 
experiments SEM. Expression of MMP12 in HaCaT keratinocytes was significantly 
















Figure 3.23b: Real-time PCR analysis of MMP12 expression in three different cell lines, 12 h 
after UVA irradiation (20J/cm2) 
Transcript levels were quantified using the B2M housekeeping gene as an endogenous 
control. The MMP12/B2M ratio was set as a baseline value to which transcript levels 
were normalized. Results are the mean of three independent experiments SEM. 

















Figure 3.24:  Real-time PCR analysis of MMP12 expression in HaCaT keratinocytes (± vit E 
pretreatment) 12 h after UVA irradiation 
Transcript levels were quantified in HaCaT keratinocytes. Results are expressed as the 
mean SEM of the MMP12/GAPDH ratio observed in three independent experiments, 





Figure 3.25: Real-time PCR analysis of MMP12 expression in MRC5V1 fibroblasts, 12 h after 
UVA irradiation 
Transcript levels were quantified using the GAPDH housekeeping gene as an 
endogenous control. The MMP12/GAPDH ratio was set as a baseline value to which 















3.6.1 In vivo study for the UVA1-induced expression of HO1 and MMP12 
 
HO1 and MMP12 data obtained in the study above were subsequently compared with 
results obtained in an in vivo study conducted by my colleague, Dr Angela Tewari. The 
UVA1 source used for the irradiation of previously unexposed buttock skin of five 
volunteers (skin types 1 and 2; age: 18-40) was a Sellamed 3000 Dr Sellmeier (Sellas, 
Gevelsberg, Germany). 
 
In contrast with the in vitro results on UVA-induced expression of HO1, the in vivo 
study conducted by Dr Tewari showed almost no upregulation of HO1 (Figure 3.26). 
The only significant increase (about 1.8-fold) observed was with a dose of 50 J/cm2, 6 h 
after UVAI irradiation, which was still extremely low compared to the approximately 
55-fold increase found in vitro. 
 
On the other hand, MMP12 was significantly upregulated in vivo with a dose of 50 
J/cm2, both 6 and 24 h after irradiation (Figure 3.27; 13-fold and 30-fold increase, 
respectively). At 6 h after UVA in vitro only a 3-fold increase was observed (Figure 
3.22), which shows a significant difference between UVA-induced MMP12 expression 










Figure 3.26:  Real-time PCR analysis of HO1 expression in vivo, 6 and 24 h following UVAI 
irradiation (relevant to untreated) 
Transcript levels were quantified using the GAPDH housekeeping gene as an 
endogenous control. The HO1/GAPDH ratio was set as a baseline value to which 















Figure 3.27:  Real-time PCR analysis of MMP12 expression in vivo, 6 and 24 h following UVAI 
irradiation (relevant to untreated) 
Transcript levels were quantified using the GAPDH housekeeping gene as an 
endogenous control. The MMP12/GAPDH ratio was set as a baseline value to which 

















3.7 ROS pathways inhibitors study 
 
 
In order to have a better understanding about the induction of 8-oxoGua and CPD 
following UVA irradiation, a mechanistic study was carried out, employing two 
inhibitors of ROS-producing enzymes. The compounds used were rotenone, a specific 
inhibitor of the mitochondrial respiratory chain complex I, and DPI, an inhibitor of 
NADPH oxidase. Therefore, targeting specific pathways of interest, an insight on the 
mechanisms by which UVA induces the formation of free radicals could be gained. 
 
Tables 3.5 and 3.6 present the effect of various concentrations (based on published 
literature) of the two inhibitors used on HaCaT cell viability. 
 
After UVA irradiation, the production of ROS was measured by FACS analysis and 
presented in Figure 3.28. Rotenone incubation (10 μM for 30 min) resulted in an 
elevation of intracellular ROS by 1.7-fold, indicating that the mitochondrial respiratory 
chain complex I plays a role in UVA-induced ROS formation. Pretreatment with DPI 
(10 μM for 30 min) significantly reduced ROS production (more than 2-fold), also 












Rotenone concentration (μM) Cell viability (%) 
0 92.5 ± 3.1 
10 79.4 ± 4.2 
50 71.8 ± 2.3 
100 65.2 ± 3.8 
200 60.5 ± 2.6 
 
Table 3.5: HaCaT cell viability following incubation (2 h) with various concentrations of 
rotenone 
Cell viability was assessed by the MTT assay. Data represent the mean of three 
independent experiments ± SEM. One-way ANOVA with Bonferroni correction showed 





DPI concentration (μM) Cell viability (%) 
0 93.2 ± 2.8 
5 91.7 ± 3.3 
10 92.8 ± 2.7 
20 89.7 ± 3.9 
 
Table 3.6:  HaCaT cell viability following incubation (2 h) with various concentrations of DPI  
Cell viability was assessed by the MTT assay. Data represent the mean of three 
independent experiments ± SEM. One-way ANOVA with Bonferroni correction showed 





Figure 3.28:  Effect of rotenone and DPI in intracellular UVA-induced ROS production 
Fluorescence intensity of H2DCFDA was excited at 488 nm. Results are the mean of 
three independent experiments SEM (values for endogenous ROS, i.e. cells not 
exposed to UVR, for both with and without inhibitors were subtracted from treatment 













Pre-treatment of cells with rotenone (100 μM for 30 min; Figure 3.29) significantly (2-
fold, p<0.0001) increased the UVA-induced DNA damage as measured by the alkaline 
comet assay (“no enz” groups). Rotenone also caused a significant upregulation (1.6-
fold, p<0.0001) of 8-oxoGua levels as measured by the hOGG1-specific comet assay, 
compared to the untreated group (control). Interestingly, a small but significant 
(p=0.01), increase was also observed in CPD formation in the + rotenone group, 
measured by the T4endoV-specific comet assay. 
 
DPI pre-treatment (10 μM for 30 min, Figure 3.30) significantly (approximately 1.9-
fold, p=0.006) reduced the UVA-induced DNA damage as measured by the alkaline 
comet assay (“no enz” groups). DPI significantly reduced 8-oxoGua levels 
(approximately 1.2-fold, p=0.04), compared to the untreated group (control). 
Furthermore, a small decrease was observed in CPD formation, but this effect did not 
reach a significant level. 
 
















Figure 3.29:  Effect of rotenone on UVA-induced DNA damage detected by the T4endoV- and 
hOGG1-modified comet assay 
The mean percentage of tail DNA in HaCaT cells exposed to UVA (5 J/cm2).  Results 
are the mean SEM of three independent experiments; p<0.0001 in all cases when 
comparing irradiated samples to their corresponding non-irradiated samples; p<0.05 in 
all cases when comparing “No enz” to “+ enz” samples, with the exception of the “+ 
rotenone” irradiated group, where the difference between “No enz” and “+T4endoV” 








Figure 3.30:  Effect of DPI on UVA-induced DNA damage detected by T4endoV- and hOGG1-
modified comet assay 
The mean percentage of tail DNA in HaCaT cells exposed to UVA (5 J/cm2).  Results 
are the mean SEM of three independent experiments; p<0.0001 in all cases when 




Figure 3.31:  Effect of pre-incubation with rotenone (rot) and DPI on UVA-induced DNA 
damage detected by the T4endoV- and hOGG1-modified comet assay (background 
corrected) 
The mean percentage of tail DNA in HaCaT cells exposed to UVA (5 J/cm2). 
Background correction was performed using no enzyme values for each group.  Results 
are the mean SEM of three independent experiments; *p<0.05 for selected 









3.8 Stiefel compounds testing against UVA-induced DNA damage and 
oxidative stress 
 
The compounds supplied by Stiefel laboratories for screening for antioxidant properties 
were initially tested for their effect on cell viability on HaCaT keratinocytes (Table 3.7). 
Based on suggestions by Stiefel, the compounds were tested at concentrations ranging 
from 5 to 80 μM. It should be noted at this point that going for concentrations higher 










































Table 3.7:  HaCaT cell viability following incubation with various concentrations of the Stiefel 
compounds  
Cell viability was assessed by the MTT assay. Data represent the mean of three 
independent experiments ± SEM. *Cells were incubated with the appropriate dilutant 
for each compound (EtOH for lanosterol, DMSO for gugglesterone and ddH2O for 
farnesol). One-way ANOVA with Bonferroni correction showed no significant 
differences between lanosterol and guggulsterone concentration increments (p>0.05 in 
all cases), but significant differences between farnesol concentration increments (p<0.05 
in all cases). 
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Farnesol was found to be toxic to HaCaT keratinocytes in a dose dependent manner, 
even at the lowest suggested dose (similar toxicity was observed in other cell lines as 
well) therefore it was dropped from the study. Following a series of investigations using 
various concentrations of lanosterol and guggulsterone, their effect on UVA-induced 
ROS production is presented in Figures 3.32 and 3.33, respectively. Treatment with 
lanosterol (for 24 h prior to UVA irradiation) reduced ROS production (approximately 
2-fold), an effect that was highly significant at a concentration of 10 μM. Guggulsterone 
treatment (for 24 h prior to UVA irradiation) on the other hand had no effect against 
















Figure 3.32:  Effect of lanosterol (10, 20 and 40 μM) in intracellular UVA-induced ROS 
production 
Fluorescence intensity of H2DCFDA was excited at 488 nm. Results are the mean of 
three independent experiments SEM (values for endogenous ROS, i.e. cells not 
exposed to UVR, for both with and without compound were subtracted from treatment 














Figure 3.33:  Effect of guggulsterone (5, 10 and 20 μM) in intracellular UVA-induced ROS 
production 
Fluorescence intensity of H2DCFDA was excited at 488 nm. Results are the mean of 
three independent experiments SEM (values for endogenous ROS, i.e. cells not 
exposed to UVR, for both with and without compound were subtracted from treatment 












Pretreatment with lanosterol (10μM for 24 h) slightly reduced UVA-induced DNA 
damage as measured by the alkaline comet assay (“no enz” groups), but the change was 
not statistically significant. That was also the case for 8-oxoGua and CPD formation 
(Figure 3.34). Guggulsterone treatment (10μM for 24 h) had no effect in UVA-induced 
DNA damage as measured by the lesion-specific comet assay (Figure 3.35). Combined 



















Figure 3.34:  Effect of lanosterol on UVA-induced DNA damage detected by T4endoV- and 
hOGG1-modified comet assay 
The mean percentage of tail DNA in HaCaT cells exposed to UVA (5 J/cm2).  Results 
are the mean SEM of three independent experiments; p<0.0001 in all cases when 
comparing irradiated samples to their corresponding non-irradiated samples; p<0.0001 










Figure 3.35:  Effect of guggulsterone on UVA-induced DNA damage detected by T4endoV- and 
hOGG1-modified comet assay 
The mean percentage of tail DNA in HaCaT cells exposed to UVA (5 J/cm2).  Results 
are the mean SEM of three independent experiments; p<0.0001 in all cases when 
comparing irradiated samples to their corresponding non-irradiated samples; p<0.05 in 












Figure 3.36:  Effect of pre-incubation with lanosterol (lan) and guggulsterone (gug) on UVA-
induced DNA damage detected by the T4endoV- and hOGG1-modified comet 
assay (background corrected) 
The mean percentage of tail DNA in HaCaT cells exposed to UVA (5 J/cm2). 
Background correction was performed using no enzyme values for each group.  Results 
are the mean SEM of three independent experiments; *p<0.05 for the selected 










































4.1 UVR-induced DNA damage 
 
Although UVB irradiation was only used at the beginning of my studies to develop the 
comet assay and slot-blot protocols, comparison of DNA damage induced with later 
experiments involving UVA, gave some interesting outcomes. As might be expected, the 
different spectra gave different distributions of damage with the comet assay; UVB was 
found to induce considerably more CPD than 8-oxoGua whilst the reverse was seen 
with UVA. 
 
4.1.1 UVA vs UVB-induced CPD formation 
 
UVB has been known for decades to cause DNA damage through direct absorption by 
DNA, however, UVA was thought to cause DNA damage mainly through indirect 
mechanisms. Although UVA-induced CPD formation had been reported in the past, 
most measures of CPD detection have not been base-specific, or they were primarily 
detected with T<>T specific antibodies. However, more recent work from the laboratory 
of Thierry Douki and his colleagues in Grenoble, provided a more detailed analysis of 
CPD production and showed (both in vitro and ex vivo) that UVAI primarily induces 
T<>T, but very few C<>C, C<>T and no 6-4PPs or Dewar isomers (Douki et al., 2003; 
Mouret et al., 2006). These findings had led to the theory of a triplet energy transfer 
from an endogenous photosensitiser to a thymine. However, a hypothetical UVA 
chromophore that absorbs UVA has not yet been definitively identified. Most recent 
research has turned the photobiology community towards the belief that CPD formation 
occurs as a result of direct absorption of UVA by DNA. This had been suggested as 
early as 1999 (Kuluncsics et al., 1999) but the latest findings showed that UVA-induced 
DNA damage is similar in isolated or plasmid DNA and cells. The absence of any 
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photosensitisers in the purified irradiation mixture used in these studies indicated that 
UVA-induced CPD formation could occur by direct absorption (Jiang et al., 2009; 
Mouret et al., 2010).  This was supported by findings that UVA induced the formation of 
CPD in a DNA duplex composed of thymine oligos (dA20:dT20), which could not have 
been contaminated by cellular components (Mouret et al., 2010). 
 
The present study measured UVB- and UVA-induced CPD levels in a cellular 
environment. The in vitro action spectrum for CPD, and in specific T<>T, has a peak at 
260 nm (Matsunaga et al., 1991), and high doses (and high fluence rates as well) of 
UVA are needed for significant CPD production, which is actually the case in recent 
UVA studies (Girard et al, 2011; Mouret et al., 2010) measuring CPD levels (in the 
range of 100-300 J/cm2, which is much higher compared to the doses used in the present 
study). 
 
Comparing DNA damage induction between the two sources used, a 50 mJ/cm2 UVB 
dose (estimated to be about 0.8 MED) was found to cause approximately the same 
amount of CPD production with a 100-fold higher UVA dose of 5 J/ cm2 (a very low 
dose in terms of erythema). A higher dose of UVB (100 mJ/cm2) induced 39% more 
CPD damage than 10 J/ cm2 and 22% more than 5 J/ cm2 UVA. Based on in vitro 
keratinocyte data (T4endoV comet assay) with different cut-off filters (Woollons et al., 
1999), it can be estimated that between ~10-25% CPD were induced by the 0.02% UVB 
content of the source in the current studies. Thus UVA was responsible for the majority 




The 8-xoGua:CPD ratio was approximately 1:6 for UVB and approximately 2:1 for 
UVA. Although some studies have shown a higher yield of CPD than 8-oxoGua levels 
following UVA irradiation in various cell lines or naked DNA (Girard et al, 2011; Douki 
et al., 2003), this was not the case in the present study. However, these ratios depend 
greatly on the spectral distribution of the source, as well as the doses used (Perdiz et al., 
2000). Woollons et al also reported different ratios for T4endoV and endonuclease III 
(which detects oxidised pyrimidines) sites with different spectra (Woollons et al., 1999). 
 
4.2 Time-course assay for UVA-induced 8-oxoGua, CPD and ALS/SB 
 
The time-course comet assay data (Figure 3.6) showed similar curves for 8-oxoGua, 
CPD and ALS/SB kinetics, possibly suggesting a similarity in the repair mechanism of 
these lesions. One study on human fibroblasts showed that the half-life for 8-oxoGua 
(Fpg-sensitive sites) was about 7 h (Eiberger et al., 2008) which is similar to my 
findings (~5 h). Also it has been shown that 8-oxoGua repair differs between various 
epidermal cell types. Specifically, 8-oxoGua repair is slower in the basal layer of the 
epidermis than in the suprabasal cells (Javeri et al., 2008). Another study (personal 
communication with my colleague M. Karbaschi from Leicester University) showed 
that the half-lives of UVA-induced CPD and ALS/SB in HaCaT keratinocytes, were also 
very similar to ours, at approximately 5 and 4 h, respectively (compared to findings of 
this study, of about 6 and 4 h, respectively). The same study also showed that UVA-
induced CPD is repaired with a much slower rate than UVB-induced CPD. This has also 
been reported by Mouret et al ex vivo (Mouret et al., 2006), but was not confirmed by 
Tewari et al who showed similar repair kinetics for UVB (300 nm) and UVAI-induced 
T<>T (Tewari et al., 2012a). It should also be noted that repair of T<>T in keratinocytes 
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in vivo is much slower (Bykov et al., 1999; Young et al., 1996) with half-lives of greater 
than 24 h. 
 
Although the comet assay also detects endogenous endonuclease activity directed at 6-
4PP as well as CPD, very few 6-4PPs would be expected from the spectra used in this 
study (Tewari et al., 2012a; Douki et al., 2003). Furthermore, 6-4PPs are known to be 
repaired with a much quicker rate than CPD (Bykov et al., 1999; Young et al., 1996). 
 
CPD are known to be removed by nucleotide excision repair (NER) (Freyer et al., 
1995), while 8-oxoGua is repaired by the base excision repair pathway (BER).  Briefly, 
the NER pathway acts by cutting out damaged bases and replacing them as directed by 
the undamaged template strand. On the other hand, the BER system differs from NER in 
the types of substrates that it recognises, as well as the initial cleavage event, which 
occurs at the glycosilic bond, as opposed to phosphodiester bond for NER (Fleck and 
Nielsen, 2004). In contrast with NER, BER detects damaged bases that do not cause a 
major distortion to the DNA helix. However, there is also evidence implicating NER in 
the repair of UVA-induced 8-oxoGua (Reardon et al., 1997), which is supported by my 
time-course data. Another possible explanation for the similarity in the repair kinetics 
may be related to the fact that the HaCaT cell line possesses mutations in both alleles of 
the p53 gene (Lehman et al., 1993). p53 is important for base excision repair (BER) 
(Offer et al., 2001) both in vitro and in vivo, and if BER is impaired, repair can be 
carried out instead by NER (Dianov et al., 1998). This argument is strengthened by a 
study in 2006 that demonstrated that loss of p53 function leads to lowered hOGG1 
repair activity (Chatterjee et al., 2006). Overall, my data provides evidence for a role for 
NER in the repair of 8-oxoGua. Whether this is specific to HaCaT keratinocytes, or is a 
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general phenomenon, remains to be elucidated. 
 
Figure 3.6 also shows an increase in the formation of both 8-oxoGua and CPD until 30 
min after UVR exposure. 8-oxoGua levels continued to increase up to 1 h after 
irradiation, while CPD levels started to decline 30 min after irradiation. This 
observation has also been reported by others for ROS in vitro (Valencia and Kochevar, 
2008) and may provide an explanation for the increase in 8-oxoGua. CPD and 8-
oxoGua levels have also been found to increase for up to 1 h following UVA irradiation 
in vitro (Javeri et al., 2011). An increase in CPD formation in vivo has also been shown 
by our group (Tewari et al., 2012a), as observed shortly after UVR exposure using 
antibody techniques. One possible explanation for this could be the unfolding of DNA 
prior to repair, that allows greater enzyme/antibody access (Duan and Smerdon, 2010). 
 
4.3 Vitamin E photoprotection 
 
Results section 3.3 showed that pre-incubation with vitamin E can offer significant 
protection against UVR-induced formation of ROS, CPD and 8-oxoGua, as well as 
ALS/SB in human keratinocytes. Vitamin E shows some absorption in the terrestrial 
UVB range (an overlap between the emission spectrum of the UVASPOT and vitamin E 
is presented in Figure 4.1) and one of the problems with some previous studies with 
vitamin E (and other antioxidants), is that it is possible that its protective effects could 
partly be attributed to optical filtering, although it is not considered to have sunscreen 
properties (Eberlein-Konig and Ring, 2005). This possibility was addressed by also 
incubating the cells post-irradiation, and similar results were observed with the lesion-
specific comet assay. The time-course assay (Figure 3.6) shows significant repair of 
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both lesions examined during the 2.5 h period of post-UVR incubation with vitamin E. 
Nevertheless, compared to the corresponding controls, the comet assay showed a 
decrease in both types of DNA damage, as well as non-specific DNA damage. However, 
one of the reasons that post-UVR incubation is effective in the comet assay is the 






Figure 4.1:  Emission spectrum of the UVASPOT, together with the absorption spectrum of a 








Some studies were performed with UVC (254 nm) radiation, which is about the peak 
wavelength in the action spectrum for CPD induction in vitro (Matsunaga et al., 1991). 
Efficacy at 300-310 nm is three orders of magnitude lower.  As can be seen in Figure 
4.1, the absorption of 254 nm by vitamin E is similar to that at about 310 nm, and 
greater than that at wavelengths longer than 310 nm. The data in Figure 3.11 show that 
monochromatic UVC induced high levels of CPDs as well as 8-oxoGua. Vitamin E 
protected against the latter but not the former, which strongly suggests that the 
protection against 8-oxoGua was not a sunscreening effect. 
 
Although induction of 8-oxoGua by UVC radiation has been reported in the past (Evans 
et al., 1999; Bruge et al., 2003), there is not much literature on UVC-induced oxidative 
stress. However, a study in 1997 demonstrated that UVC-induced 8-oxoGua is due to 
increased singlet oxygen (1O2) formation following UVC irradiation (Zhang et al., 
1997). It is often stated that UVA is the main cause of oxidative stress, however, it 
should not be forgotten that this can also be caused by other wavebands, including UVB 
(Perluigi et al., 2010). 
 
Since UVA-induced 8-oxoGua is formed indirectly, predominantly via 1O2 (Cooke et al., 
2003; Zhang et al., 1997), the antioxidant properties of vitamin E were not surprising. 
This protective effect has not previously been demonstrated for this lesion by the comet 
assay. However, a 2004 study showed a protective effect of vitamin E against 
oxidatively-induced 8-oxoGua in ovarian epithelial cells (Murdoch and Martinchick, 
2004), while an older report illustrated an inhibitory effect of vitamin E against ozone-
induced 8-oxoGua (Cheng et al., 2003). In general, vitamin E has been established as a 
UVR-induced ROS scavenger (Jin et al., 2007). A very recent study by a former 
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colleague also showed a protective effect of vitamin E against cis-UCA-induced ROS 
formation, indicating a role of the antioxidant in indirect photoprotection (Kaneko et al., 
2011). 
 
In contrast, the formation of CPD is thought to occur mainly via direct photon 
absorption, especially in the UVC and UVB regions. However, the sensitized formation 
of T<>T in naked DNA in this spectral region has been reported (Kaneko et al., 1979). 
The photochemical mechanism by which UVA (and more specifically UVAI) selectively 
induces CPD formation is still not completely clear. It is known that UVA activation of 
certain photosensitizers can induce CPD in vitro, as was also recently shown with 
carprofen (Robinson et al., 2010). Therefore, unidentified endogenous photosensitizers 
might play a role in UVA-induced CPD, especially in the more complex in vivo system. 
However, DNA absorbs weakly in the whole UVA region (Sutherland and Griffin, 
1981), so CPD formation by direct absorption can occur and has been recently reported, 
as mentioned above (Jiang et al., 2009; Mouret et al., 2010).  
 
Post-UVA treatment with vitamin E was also found to offer significant protection 
against ROS production, with a similar trend to the pre-UVA experiment. Greater mean 
fluorescence values in the post-UVA treatment experiment (Figure 3.9) might either 
indicate an enhanced post-UVA ROS, which has been reported by others in 
keratinocytes (Valencia and Kochevar, 2008),  or an increase in stress caused to cells 
due to harsher protocol conditions compared to the pre-UVR experiment. Figure 3.6 
shows an increase of enzyme-specific DNA damage up to an hour post-UVA, which 
may also implicate post-UVA ROS release, especially with 8-oxoGua. 
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In contrast, DNA damage levels measured by the comet assay were lower in the post-
UVR treatment experiment, in both hOGG1 and T4endoV groups (Figure 3.10). This 
decrease possibly indicates that the 2.5 h incubation period was enough for some repair 
(especially of ALS, considering the timeframe) as shown in Figure 3.6. Post-UVA 
incubation with vitamin E resulted in a significant reduction of non-specific (ALS/SB) 
and T4endoV and hOGG1-specific DNA damage. Levels for both lesions were found to 
be slightly lower (both approximately 5%) compared to the same time point (2.5 h) of 
the time-course assay (Figure 3.6), which indicates that data between different 
experiments are consistent. This small change could be attributed to different 
experimental conditions that involved the addition of EtOH (control) or vitamin E in 
fresh DMEM for the post-UVA vitamin E experiment, as opposed to the transfer of cells 
back to their conditioned DMEM for the 2.5 h period of incubation following UVR, for 
the time-course assay. 
 
The immuno-slot blot experiment (Figure 3.13) supported the pre-UVR incubation data 
of the T4endoV comet assay; this was not the case with the post-UVR incubation 
results, where no significant effect of vitamin E was observed. A possible explanation 
for this may be the lack of CPD specificity of the T4endoV comet assay, which has also 
been shown to detect FapyAde sites (Dizdaroglu et al., 1996). Furthermore, T4endoV 
has an apurinic/apyrimidinic site endonuclease activity (Epe et al., 1993), which might 
lead to an overestimation of CPD. 
 
It should also be noted that the T4endoV enzyme recognizes all types of CPD, T<>T, 
T<>C and C<>C, which based on findings by Douki et al in UVA-irradiated CHO cells, 
are produced with a ratio of  89:9:4, respectively (Douki et al., 2003). In contrast, the 
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immuno slot-blot assay is primarily specific for T<>T, which is the most frequent type 
of UVA-induced CPD (Mitchell et al., 1992; Rochette et al., 2003). Although the 
mechanisms are not yet understood, UVA, especially UVAI, readily induces the 
formation of T<>T but not the other CPD (Mouret et al., 2006; Rochette et al., 2003) 
that are also induced primarily with UVB sources (You et al., 2001). Thus, it is possible 
that T<>T are not formed post-UVA, whereas other CPD are, as indicated in Figure 3.6. 
This could also relate to the fact that CPD have different repair kinetics, with T<>C 
being repaired faster (Bykov et al., 1999). 
 
Another possible explanation for the effects of vitamin E on DNA damage is the 
upregulation of DNA repair through reduction of ROS (Rassool et al., 2007). ROS as 
well as reactive nitrogen species (RNS) can decrease the efficiency of DNA repair 
enzymes and DNA polymerase (for both NER and BER) through oxidative protein 
damage (Wiseman and Halliwell, 1996). This theory has also been suggested recently 
and was based on suppression of UVA-induced nitric oxide (NO) products through post-
UVR treatment with 1α,25-dihydroxyvitamin D3 (1,25D). The authors proposed a 
mechanism by which  1,25D suppresses NO products, thus enhancing DNA repair; this 
resulted in less DNA damage, with reduced CPD formation, reduced 
immunosuppression and reduced photocarcinogenesis (Mason et al., 2010). Therefore, it 
would be interesting to assess the effect of vitamin E on CPD and 8-oxoGua repair 
kinetics (see Future perspectives; section 4.9). 
 
Overall, present data suggest that photoprotection by vitamin E should not be attributed 
to its UVR absorbing properties. There is literature to suggest that vitamin E protects 
against UVB-induced CPD formation (Chen et al., 1997; McVean and Liebler, 1997). 
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Some studies have also shown that vitamin E is capable of protecting against UVB-
induced erythema, even if applied 8 h after UVR (Trevithick et al., 1993), and UVB-
induced skin cancer in hairless mice (Berton et al., 1998). This effect has been observed 
both in vitro and in vivo, in mouse skin and has been attributed to the inhibition of CPD 
formation (Cario-Andrè et al., 2002; McVean and Liebler, 1999). However, results have 
varied, depending on the method of vitamin E application (topical or systemic), as well 
as the chemical form used in each study. This clearly illustrates why it is important to 
understand how this potent antioxidant is also able to protect against types of damage 
other than that induced by free radicals.  
 
Endogenous vitamin E can prevent UVR-induced lipid peroxidation by acting as a 
chain-breaking antioxidant in the skin. Vitamin E (α-tocopherol), used in the present 
study, appears to be more effective than other commercially available forms such as 
tocopherol acetate or α-tocopheryl succinate (Werninghaus et al., 1994). The ability of 
Vitamin E to protect against UVR-induced cytotoxicity correlates with its level of 
uptake into cells and the level of its incorporation into the cell membranes has been 
correlated with its protection (Sakagami et al., 1997). Furthermore, photooxidation of 
vitamin E forms certain photoproducts with photoprotective properties (Krol et al., 
2000). Finally, it has been reported that vitamin E interacts with endogenous antioxidant 
enzymes, playing a central role in recycling the antioxidant defence system in human 
cells (Wu et al., 2008; Petersen et al., 2000). Combinational studies of vitamins C and E 
have proven the protective effect of these antioxidants against sunburn (Eberlein-Konig 
and Ring, 2005) and UVB-induced T<>T (Placzek et al., 2005). 
 
In summary, vitamin E is able to protect against different types of photodamage induced 
by solar range UVR and this is not related to its optical properties. Vitamin E is also 
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able to protect against oxidatively induced damage post-UVR. Our findings, as well as 
recent literature, suggest that UVA-induced ROS may play a role in the production of 
CPD at the cellular level (Petersen et al., 2000; Hochberg et al., 2006).  This could be 
attributed to the interaction of ROS with histones, which can affect the nucleosome, 
opening the chromatin structure, which would lead to increased thymidine accessibility 
to UVR (Hawkins et al., 2002). Strong evidence supporting this argument has been the 
inability of vitamin E to protect against CPD formation on naked DNA (Hochberg et al., 
2006). Another possible explanation mentioned earlier in the discussion, would be the 
ROS-induced downregulation of DNA repair through protein oxidation by UVA-
induced radicals. In favour of this hypothesis was the finding that UVA induces 
oxidative crosslinking (through 1O2 production) between the subunits of the replication 
and repair protein, proliferating cell nuclear antigen (PCNA) (Montaner et al., 2007). As 
discussed earlier, UVA-induced ROS are also known to activate several MAPKs 
(Silvers et al., 2003; Son et al., 2011), therefore, by affecting various downstream 
effectors (such as AP-1 and NFκB) they may alter DNA repair responses, cell cycle 
arrest or apoptosis (Ridley et al., 2009). Furthermore, a study by Berton et al in 1998 
showed that vitamin E treatment post-UVB irradiation increased CPD repair and this 
result was correlated with decreased p53 protein levels (Berton et al., 1998). 
 
An ideal sunscreen would be able to protect against DNA damage and oxidative stress, 
as well as erythema. Our data, as well as those from other groups (Greul et al., 2002; 
Oresajo et al., 2010; Jiang et al., 2009; Matsui et al., 2009; Mouret et al., 2010), support 
the role of antioxidants in sunscreens, and possibly after-sun preparations. However, 
several questions remain to be addressed regarding the chemistry behind the protection 
offered by vitamin E, and it is important to establish if similar protection levels could be 
exhibited for the human skin. 
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4.4 NAC photoprotection 
 
Figure 2.2 shows that NAC does not absorb in the spectral range of the UVR source 
used in this study. NAC protected against UVA-induced ROS formation (Figure 3.15) 
and UVA-induced GSH depletion (Figure 3.16). It also reduced 8-oxoGua levels but did 
not significantly alter CPD formation (Figure 3.17). An older study had demonstrated a 
protective effect of NAC against UVA-induced DNA damage using the comet assay, but 
this was done without the use of any lesion-specific enzymes (Morley et al., 2003). A 
recent study showed that NAC treatment on HaCaT keratinocytes strongly inhibited 
ROS and NO production induced by nano-titanium dioxide and UVA (Xue et al., 2011). 
NAC has been used in several antioxidant studies as its major function is to act as a 
cysteine donor, maintaining or even increasing intracellular GSH levels, thus protecting 
cells against free radicals. This effect was also shown in the present study, where NAC 
increased GSH levels in HaCaT keratinocytes (control group) by 2.7-fold, and offered a 
significant protection against UVA-induced depletion of total GSH as well (Figure 
3.16).  
 
4.5 UVA-induced HO1 and MMP12 gene expression 
 
HO1, a redox-regulated enzyme that catalyses the degradation of heme to release 
biliverdin and carbon monoxide (CO), is a reliable indicator of cellular oxidative stress 
(Allanson and Reeve, 2004). HO1 gene and protein levels are hugely upregulated in 
skin fibroblasts due to UVA irradiation (Keyse and Tyrrell, 1989), but that effect has not 
always been observed in various keratinocyte cell lines (Applegate et al., 1995). A 2006 
study also found that UVA-induced HO1 expression may offer immunoprotection 
against UVB irradiation in mouse skin (Reeve et al., 2006). 
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In the present study, HO1 gene expression was significantly upregulated following UVA 
irradiation of HaCaT keratinocytes, with a peak at 3 h (Figure 3.18). HO1 levels were 
slightly but significantly decreased following 24 h pretreatment with vitamin E in both 
HaCaT keratinocytes and MRCV1 fibroblasts (Figures 3.20 and 3.21). This effect had 
only been shown as a secondary result of a 1999 study, in which β-carotene had failed to 
protect against UVA-induced HO-1 gene expression, in contrast with vitamin E 
(Obermuller-Jevic et al., 1999). 
 
Interestingly, HO1 was not found to be significantly induced in whole skin (epidermis 
and dermis) in vivo following pure UVAI irradiation (Figure 3.26), in a study conducted 
by my colleague Dr Tewari (which was based on a former pilot study partially done by 
me). This may highlight the variation of HO1 expression between in vitro and in vivo 
circumstances, since UVA doses used were comparable (20 J/cm2 in vitro and 12.5-50 
J/cm2 for the in vivo study). However, there was a difference in the time-points tested, as 
the in vitro work had shown a maximum upregulation of HO1 3 h after UVR and a 
significant decline 5 h after UVR (Figure 3.18). The in vivo experiment studied HO1 
expression only at 6 and 24 h after UVR, but expression was also higher at 6 h. 
 
There is no literature on UVA-induced MMP12, which was chosen for analysis as a 
highly upregulated gene in an in vivo UVA pilot study. MMP12 is a member of the 
MMP family, and the most active MMP against elastin (Chen et al., 2004). MMP12 is 
involved in the degradation of elastic fibres in various skin disorders (Vaalamo et al., 
1999; Saarialho-Kere et al., 1999). 
 
MMP12 mRNA and protein has been shown to be induced by UVB irradiation in 
human skin in vivo and it was demonstrated that it is increased in photoaged skin and 
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has a significant role in the development of solar elastosis (Chung et al., 2002). The 
same study showed that NAC and vitamin E were both able to inhibit UVB-induced 
MMP12 gene expression in human skin in vivo, while a more recent study showed that 
UVB-induced MMP12 protein production could be prevented by an antioxidant-derived 
product (Afaq et al., 2009). 
 
MMP12 was only 4-fold upregulated by UVA irradiation in vitro (Figure 3.23). 
However, it was more upregulated in vivo (Figure 3.27), making it a possible new 
marker of oxidatively-induced DNA damage. However, vitamin E had no significant 
effect on MMP12 expression in vitro (Figures 3.24 and 3.25). The in vitro time-course 
experiment for MMP12 expression showed a maximum 12 h after UVR, with a decline 
at 18 h (Figure 3.22). In contrast, the in vivo study showed a maximum expression at 24 
h following UVR, indicating a difference between in vitro and in vivo environments. 
 
Based on the in vivo data with a pure UVAI source, MMP12 presents an appealing 
possible new marker for UVA-induced oxidative stress and photoageing and it would be 
interesting to be studied in more detail in vivo, and possibly in older subjects. In the 
more complex in vivo environment, antioxidants, and in specific vitamin E, might be 
able to exhibit a protective effect over time. The mechanism of induction of MMP12 in 
the human skin is also an interesting field of study, since MMPs have been shown to be 
triggered through different pathways. For example, MMP1 (the major enzyme 
responsible for collagen 1 digestion) protein expression has been linked with increased 
oxidative stress (Fisher et al., 2009), but also with direct, UVB-induced DNA damage 
(Dong et al., 2008). The involvement of ROS in UVAI-induced erythema, as well as 
evidence by MMP1 studies have suggested that DNA along with an unknown UVAI 
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absorbing molecule that probably generates ROS, are shared chromophores for 
erythema and MMP-1 induction (Dong et al., 2008; Scharffetter-Kochanek et al., 1993; 
Auletta et al., 1986). This hypothesis is also supported by recent findings of our group 
(Tewari et al., 2012b). Therefore, vitamin E could be a promising agent against 
photoageing, as it is implicated in both oxidative stress and direct DNA damage, as 
discussed earlier.  
 
4.6 Role of mitochondrial respiratory chain complex I and NADPH in 
UVA-induced DNA damage 
 
The results with the hOGG1-modified comet assay showed a decrease of 8-oxoGua 
when keratinocytes were pretreated with vitamin E for 24 h, but also when they were 
treated with the compound after UVR, for 2.5 h. This might indicate a cascade of events 
taking place after the initial photoreaction, which prolongs the existence of ROS, 
through 1O2 production (Ouedraogo and Redmond, 2003; Valencia and Kochevar, 
2008). 
 
A possible mechanism for the generation of such ROS would involve UVA-induced 
enzyme activity. An enzyme proposed to play an important role is NADPH oxidase 
(Valencia and Kochevar, 2008). NADPH oxidase has been shown to cause increased 
superoxide (O·2-) generation in response to UVA in mouse, monkey and human cell lines 
(Hockberger et al., 1999). The resulting O·2- increase and its subsequent conversion to 
other ROS causes increased cellular and DNA damage. Prolonged generation of free 
radicals by such mechanisms in the initially exposed cells and their progeny therefore 
have the potential to cause severe genome instability (Ridley et al., 2009). 
 
 171
The probe used for ROS detection in this project was H2DCFDA, which is not specific 
for one type of ROS but reacts with several species in cells, including H2O2, NO and 
peroxides (Possel et al., 1997; Afri et al., 2004). Therefore, all types of free radicals 
produced immediately after, but also much later than the UVA irradiation (as seen in the 
post-UVA vitamin E ROS experiment; Figure 3.9) were detected by the assay. 
 
Since recent literature has highlighted the production of CPD, especially T<>T, due to 
UVA irradiation, it has been debated recently whether this takes place through a direct 
or an indirect mechanism (Girard et al, 2011). The comet assay results exhibited a 
protective effect of vitamin E against CPD formation, both after 24 h pre-treatment and 
after 2.5 h post-UVR treatment. This could indicate an involvement of ROS in the 
production of CPD, a mechanism also suggested by Hochberg and colleagues 
(Hochberg et al., 2006), as discussed in detail in section 4.3. 
 
Since the mitochondrial respiratory chain is a major source of ROS generation in the 
cells, it was decided to assess its role in UVA-induced oxidative stress. The use of 
rotenone -an inhibitor of the mitochondrial respiratory complex I- led to an increase in 
ROS formation as measured by the ROS assay, but also increased 8-oxoGua formation 
as measured by the hOGG1-modified comet assay (Figures 3.28 and 3.29). This 
upregulation of ROS and oxidatively-generated DNA damage by rotenone highlights 
the role of mitochondria in UVA-induced damage. It is now well established that the 
vast majority of cellular ROS are produced in mitochondria, “leaking” from the 
respiratory chain (Birch-Machin and Swalwell, 2010). Furthermore, the mitochondrial 
inner membrane contains several potential chromophores that can absorb UVA (such as 
flavoproteins, nicotinamide dinucleotides, ubiquinone, and cytochrome c1) and are 
capable of initiating photodynamic reactions (Schauen et al., 2007). Since UVA may 
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cause severe mitochondrial DNA damage, which persists longer than nuclear DNA 
damage (Yakes and Van Houten, 1997), it could generate sufficient ROS that reach the 
nucleus and cause further DNA damage. However, a 2004 study suggested that although 
visible light-induced mitochondrial ROS are responsible for most ROS present in the 
cells, they were not responsible for a significant 8-oxoGua formation, as measured by 
the Fpg-comet assay (Hoffmann et al., 2004), a finding that contradicts what was 
observed in the present study. This might relate to the use of Fpg, which has been shown 
to be less accurate than hOGG1 in 8-oxoGua detection (Smith et al., 2006). Treatment 
of cells with rotenone caused a small but not significant reduction in CPD formation 
(Figure 3.31), indicating it had no effect on this endpoint.  
 
Data of rotenone-induced mitochondrial ROS measured at the cellular level have been 
inconsistent between studies. Rotenone has been shown to elevate cellular ROS 
production in some cases (Deng et al., 2010; Barrientos and Moraes, 1999) while 
inhibiting cellular ROS production in others (Vrablic et al., 2001; Schuchmann and 
Heinemann, 2000). Overall, findings of this study clearly show a role of the 
mitochondrial respiratory complex I in the production of UVA-induced ROS and 
oxidatively-induced DNA damage, but do not suggest a significant role of 
mitochondrial ROS in CPD formation. 
 
The other inhibitor used was DPI, which is a specific inhibitor of NADPH oxidase, a 
major “player” in UVA-induced damage. NADPH oxidase inhibition by DPI has been 
shown to significantly attenuate UVA-induced ROS (He et al., 2005). Pretreatment of 
cells with DPI resulted in reduced ROS formation following UVA irradiation (Figure 
3.28) and also a significant decrease of 8-oxoGua levels (Figure 3.31). Combined with 
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the observation of increased ROS levels 2.5 h after irradiation (Figure 3.9 compared to 
Figure 3.7), these results come in agreement with recent literature implicating NADPH 
oxidase in UVA-induced ROS production in HaCaT keratinocytes (Henri et al., 2011). 
Other studies found increased levels of ROS, detected up to at least 2 h following 
irradiation, suggesting that continued production of ROS is activated by UVA, possibly 
through a “feed forward” mechanism by H2O2, which further activates NADPH oxidase 
(Valencia et al., 2006; Li et al., 2001). Since NADPH oxidase and mitochondria are the 
major cellular sources of the ROS detected shortly after UVA exposure (Valencia and 
Kochevar, 2008) they are key “players” in UVA-induced DNA damage. In general, this 
“secondary ROS” production that can be a result of lipid peroxidation (which can be 
prevented by vitamin E) might initiate further oxidative DNA damage (such as 8-
oxoGua, lipid and protein oxidation) in the nucleus (Ouedraogo and Redmond, 2003), 
as discussed above.  
 
In summary, DPI reduced ROS and 8-oxoGua formation through inhibition of NADPH 
oxidase activity, indicating a major role of this signalling pathway in UVA-induced 
damage. On the other hand, DPI had no significant effect in UVA-induced CPD 
production, ruling out an involvement of NADPH oxidase in the formation of CPDs. 
 
Using the two specific inhibitors rotenone and DPI, this study revealed a role of the 
mitochondrial respiratory chain, as well as NADPH oxidase in UVA-induced ROS 







4.7 Stiefel compounds with antioxidant potential 
 
 
Of the three compounds supplied by Stiefel laboratories, one (farnesol) was found to be 
toxic. Lanosterol, a precursor of cholesterol in mitochondria and other cellular 
compartments of macrophages, has been found to be upregulated under increased 
oxidative stress conditions, suggesting a possible role of it in cellular response to stress 
(Andreyev et al., 2010). There is not much literature about lanosterol, however a recent 
study provided evidence that it might be a neuroprotective agent in a model of 
Parkinson’s disease, acting through mitochondrial uncoupling induction and by 
promoting autophagy (Lim et al., 2012). In the present study, lanosterol significantly 
reduced ROS levels and also offered a small but significant protection against UVA-
induced 8-oxoGua formation. Based on its spectral properties (Figure 2.5) as well as its 
high viscosity (very difficult to dilute and difficult to rinse following incubation, even 
after thorough washing with PBS), a sunscreen effect of lanosterol could not be 
excluded, although the inability to protect against UVA-induced CPD formation 
contradicts this hypothesis. 
 
The phytosterol guggulsterone is a constituent of the Indian plant Commiphora mukul, 
and has been considered as a potent anti-inflammatory mediator (Deng, 2007). The 
repression of NF-κB activation by guggulsterone has been proposed as a mechanism of 
its anti-inflammatory properties (Shishodia and Aggarwal, 2004). Although a relatively 
recent study showed that guggulsterone attenuated H2O2-induced cytotoxicity and 
intracellular accumulation of ROS (Xu et al., 2008), this study did not find a significant 
effect of guggulsterone against UVA-induced ROS or UVA-induced DNA damage 
(Figures 3.33 and 3.35). Higher concentrations than the ones used here, might prove 
more beneficial (although cell viability assays showed a decline in cell survival with 
 175
high guggulsterone concentrations; Table 3.7). 
 
In general, this study suggests a possible role of lanosterol in photoprotection, since it 
significantly protected against ROS and reduced oxidatively-induced DNA damage 
caused by UVA irradiation. Guggulsterone had no effect in the endpoints tested, but this 
could be attributed to low the concentrations used in the present study. Higher 
concentrations used in other studies with guggulsterone (none of which tested it against 
UVR-induced damage) could not be reached under this study’s conditions, since the 


































4.8 General conclusions 
 
This project generated a panel of quantitative techniques that measure UVR-induced 
damage and the photo-protective effects of various compounds against its deleterious 
effects. All studies were done under conditions of high cell viability with UVR doses 
that were environmentally and physiologically relevant. 
 
A major finding was the beneficial effects of vitamin E when administered post-
irradiation. This suggests that antioxidants may be useful in after-sun products, not only 
to counteract oxidative stress, but possibly aid in DNA repair. Vitamin E treatment, both 
before and after UVR, protected against ROS and 8-oxoGua formation, suggesting it is 
an ideal compound to counteract oxidatively generated damage by UVA irradiation. The 
results obtained by the T4endoV-modified comet assay also showed a protective effect 
of vitamin E against UVA-induced CPD, again both pre- and post-UVR. T<>T 
measurement by the immuno-slot blot revealed the same protective effect of vitamin E 
for pre-UVA treatment, but no significant protection with the post-UVA treatment. As 
mentioned previously, a possible interpretation of this observation could be the lack of 
specificity of the T4endoV-modified comet assay for T<>T (Dizdaroglu et al., 1996; 
Epe et al., 1993). 
 
Although latest research has shown that UVA-induced CPD formation is due to direct 
absorption of UVA by DNA, this study along with recent literature highlights the 
importance of oxidative stress in DNA damage, indirectly, possibly by influencing DNA 
repair processes. Although UVA-induced ROS can cause direct oxidative damage to 
DNA, as evidenced by the increase in 8-oxoGua, they may also inhibit proteins 
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involved in the DNA repair process, enabling the accumulation of forms of DNA 
damage that are not directly caused by ROS, such as CPD (Halliday, 2010). Some 
results of this study suggested a role of ROS in the formation of UVA-induced CPD, as 
evidenced by the protection offered by vitamin E. However, post-UVR treatment with 
vitamin E did not protect against T<>T formation, as measured by the immuno-slot blot 
adding difficulty toward a definitive interpretation. Furthermore, mitochondrial ROS 
and NADPH oxidase were not found to be associated with UVA-induced CPD 
production, ruling out a direct involvement of ROS in their formation. Vitamin E might 
have a different mechanism of protection when applied pre- or post-UVR. Pre-UVR 
treatment may protect through partial absorption of UVB (0.2% UVB in the source 
used), thus reducing CPD formation (although the impact would be quite small), 
whereas post-UVR treatment could aid CPD repair. 
 
In general, findings of this study show that vitamin E is an ideal compound for products 
that could be applied both before and after exposure to UVR, especially since recent 
findings showed that it is stable under UVR (long-wave UVA; 365 nm) for up to 6 h 
(Sabliov et al., 2009). However, the method of application and the vehicle used for its 
application on human skin are of great importance for its photostability. 
 
Since data obtained in this project were produced with a (primarily UVAI) source 
containing 0.2% UVB, some CPD production could be attributed to UVB. However, the 
difference between CPD and 8-oxoGua levels when comparing data between obtained 
with the UVA source and the UVB source, suggest that the majority of CPD caused by 
the UVASPOT, was due to the UVA component. 
 
 178
A crucial point highlighted by the study of UVA-induced genes is the interpretation of in 
vitro data, as exemplified by the HO1 results in vivo. UVA-induced HO1 expression was 
analysed in more than one cell types with similar results, but this was not seen in the in 
vivo study which was conducted on 5 volunteers, offering a statistical significance to the 
obtained results. 
 
Since recent evidence showed that CPD is the principal lesion produced by terrestrial 
sunlight (Besaratinia et al., 2011), photoprotection strategies should focus on how to 
inhibit its formation. Importance of photoprotection against UVA damage is also 
highlighted by latest findings that UVA-induced CPD are more mutagenic than those 
induced by UVB (Runger et al., 2012). Furthermore, it has been shown that UVA-
induced T<>T formation is more abundant in the basal epidermis (Tewari et al., 2012a; 
Huang et al., 2009), an important finding, since that is where stem cells are located. 
Therefore, CPD in the basal layer could be an ideal marker of UVA-induced DNA 
damage, and possibly reflect other types of damage, such as 8-oxoGua. Another 
important aspect to bear in mind is the difference in CPD repair between in vitro and in 
vivo environments. Although UVA-induced T<>T were thought to be repaired less 
efficiently than UVB-induced T<>T as found ex vivo (Mouret et al., 2006), a more 
recent study showed that this was not the case in vivo, where a similar repair rate was 
observed between the two (Tewari et al., 2012a). Furthermore this study showed a 
relatively rapid repair of T<>T in vitro, compared to in vivo studies (Bykov et al., 1999; 
Tewari et al., 2012a; Young et al., 1996). This emphasizes the need to distinguish 




Results of this project also indicated that NADPH is a key player in UVA-induced DNA 
damage. NADPH oxidase has been found to be inhibited by vitamin E in vitro (Wu et 
al., 2008). A recent study has pointed out a role of NADPH in tissue repair, through 
various signalling pathways (Chan et al., 2009). Therefore a possible mechanism of 
vitamin E photoprotection could be the enhancement of DNA repair, through 
downregulation of NADPH oxidase. A schematic representation of the main findings of 
this study is shown in Figure 4.2. 
 
In the end, it is important to stress the variation of UVA spectra, doses, as well as 
fluence rate (irradiance) between different studies measuring UVA-induced CPD. High 
fluence rates of UVA have been shown to increase oxidatively-induced DNA damage in 
skin cells (Hoerter et al., 2008), therefore it is also important to note these 
measurements before comparing between studies. All these are highlighted by the 
disagreement regarding the relative yields of 8-oxoGua and CPD in the UVA range. 
Large UVA doses have been shown to give rise to more CPDs than oxidised purines, 
therefore, comparisons could be misleading (Pfeifer and Besaratinia, 2012). 
Furthermore, discrepancies in repair rates of CPD and 8-oxoGua induced by UVA 







                                                                                                 
 180
 
Figure 4.2:  UVA effects on human skin cells based on literature and findings of this thesis 
 
(1) The H2DCFDA/ROS assay demonstrated the production of various ROS following 
UVR. Some of these ROS where also present/generated up to 2 h post-irradiation, as 
indicated by the protection offered by vit E post-UVR. NADPH oxidase and 
mitochondrial complex I were found to be involved in UVA-induced production of ROS 
(and as a result, of 8-oxoGua), as shown by the ROS and comet assays with the use of 
DPI (NADPH oxidase inhibitor) and rotenone (mitochondrial complex I inhibitor). 
(2) The hOGG1-modified comet assay showed that UVA induces 8-oxoGua formation, an 
effect which is alleviated by vit E, both pre- and post-UVR 
(3) The T4endoV-modified comet assay revealed the formation of CPD following UVA, 
which was reduced by pre- and post-UVR treatment with vit E. 
(4) The immuno-slot blot (ISB) showed the production of CPD due to UVA irradiation and 
demonstrated a significant protection by vit E pre-treatment. However, this was not the 







4.9 Further perspectives 
 
The work presented in this thesis lends itself to further studies, both in vitro and in vivo. 
The data for induction of ROS and 8-oxoGua and their inhibition by vitamin E are 
generally consistent and the assays involved could be used to assess other potential 
antioxidants. Post-UVR treatment would be important to exclude protection by any 
UVR absorbing properties. The results for CPD are less clear cut and further 
experiments are necessary to establish any role of ROS in CPD induction and the effect 
of ROS on CPD repair, and indeed 8-oxoGua repair, as well as any effects of 
antioxidants on repair capacity. It would also be important to do comparative studies in 
skin cells with normal p53 status. Furthermore it would be informative to perform 
studies with pure UVB and UVAI sources (e.g. monochromatic radiation) as well as 
solar simulated radiation. 
 
The DNA photolesion and gene expression studies developed here in vitro can be 
readily translated into the human skin in the in vivo situation. My colleague Dr Angela 
Tewari has a large amount of UVB (300 nm) and UVAI microarray data for the whole 
genome in human skin. These could be used, along with in vitro data, to identify UVR-








Some specific experiments that could be performed are listed below: 
 
 The possible effects of vitamin E (and other antioxidants) can be studied in vivo 
against UVAI-induced CPD and 8-oxoGua formation. This could be done using 
antibody techniques which also allow the location of the damage in the epidermis 
and dermis, as well as double staining techniques to allow the identification of 
specific cell types (e.g. melanocytes). 
 
 Further investigation could also be conducted on different repair rates between 
UVA- and UVB-induced DNA damage, since there are some discrepancies on the 
repair kinetics of CPD and 8-oxoGua in recent literature. Most importantly, great 
attention should be given to UVR spectra, in order to make comparisons between 
studies valid. ROS may interfere with DNA repair: thus it would be interesting to 
assess this possibility in vitro and in vivo. 
 
 Recent literature has also pointed to the continued ROS formation following UVA 
irradiation. Although many hypotheses have been made about this phenomenon, it 
still remains to be fully elucidated, especially since the mechanism of activation of 
NADPH by UVA is still unknown. Further studies with inhibitors of ROS pathways 
and the consequences of such inhibition can also be conducted. 
 
 A time-course experiment to measure ROS levels at different time points after 
irradiation is planned. This will provide further information on the involvement of 
secondary ROS production in UVA-induced DNA damage. This experiment will 
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